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This dissertation addresses two problems from novel perspectives. In chap-
ter 2, I propose an empirical likelihood based method to nonparametrically adjust
for baseline covariates in randomized clinical trials and in chapter 3, I develop a
survival analysis framework for multivariate K-sample problems.
(I): Covariate adjustment is an important tool in the analysis of randomized
clinical trials and observational studies. It can be used to increase efficiency and
thus power, and to reduce possible bias. While most statistical tests in random-
ized clinical trials are nonparametric in nature, approaches for covariate adjust-
ment typically rely on specific regression models, such as the linear model for a
continuous outcome, the logistic regression model for a dichotomous outcome, and
the Cox model for survival time. Several recent efforts have focused on model-free
covariate adjustment. This thesis makes use of the empirical likelihood method
and proposes a nonparametric approach to covariate adjustment. A major advan-
tage of the new approach is that it automatically utilizes covariate information in
an optimal way without fitting a nonparametric regression. The usual asymptotic
properties, including the Wilks-type result of convergence to a χ2 distribution for
the empirical likelihood ratio based test, and asymptotic normality for the cor-
responding maximum empirical likelihood estimator, are established. It is also
shown that the resulting test is asymptotically most powerful and that the esti-
mator for the treatment effect achieves the semiparametric efficiency bound. The
new method is applied to the Global Use of Strategies to Open Occluded Coro-
nary Arteries (GUSTO)-I trial. Extensive simulations are conducted, validating
the theoretical findings. This work is not only useful for nonparametric covariate
adjustment but also has theoretical value. It broadens the scope of the traditional
empirical likelihood inference by allowing the number of constraints to grow with
the sample size.
(II): Motivated by applications in high-dimensional settings, I propose a novel
approach to testing equality of two or more populations by constructing a class
of intensity centered score processes. The resulting tests are analogous in spirit
to the well-known class of weighted log-rank statistics that is widely used in sur-
vival analysis. The test statistics are nonparametric, computationally simple and
applicable to high-dimensional data. We establish the usual large sample prop-
erties by showing that the underlying log-rank score process converges weakly to
a Gaussian random field with zero mean under the null hypothesis, and with a
drift under the contiguous alternatives. For the Kolmogorov-Smirnov-type and
the Crame´r-von Mises-type statistics, we also establish the consistency result for
any fixed alternative. As a practical means to obtain approximate cutoff points
for the test statistics, a simulation based resampling method is proposed, with
theoretical justification given by establishing weak convergence for the randomly
weighted log-rank score process. The new approach is applied to a study of brain
activation measured by functional magnetic resonance imaging when performing
two linguistic tasks and also to a prostate cancer DNA microarray data set.
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Chapter 1
Introduction
Formally suggested by R.A. Fisher in the 1920s (Box 1980), randomization was
first used in medical studies by Bradford Hill and Richard Doll in Great Britain
in the 1940s. In the United States randomization was advocated by early trialists
such as Tom Chalmers and Paul Meier (Piantadosi 2005). Nowadays, randomiza-
tion is widely adopted in the design of clinical trials and other experiments for
comparing treatments (Hill 1960; Byar et al. 1976). Without randomization, the
possibility that the allocation of patients to treatments is consciously or uncon-
sciously based on patients’ prognostic factors can not be precluded (Efron 1971).
Because selection bias can influence outcomes as strongly as many treatment ef-
fects, treatments yielding differences of a clinically important size could then be
due only to the bias in selection. Thus, randomization prevents confounding of
the effects of the therapy with the prognostic factors. A more far-reaching benefit
of randomization is that it provides a valid basis for testing the null hypothesis
of no treatment effect without any assumption of a population model and with-
out the necessity of measurements on all the possibly important covariates, which
gives randomized studies their high degree of inferential directness and reliability
CHAPTER 1. INTRODUCTION 2
(Fisher 1966; Kempthorne 1977; Lehmann 1975).
The primary objective of many randomized clinical trials is to compare the
difference in mean outcome among two or more treatments. In addition to the
primary outcome and treatment assignment, substantial amounts of baseline data
on each subject prior to randomization are routinely collected. These data may in-
clude patient demographic characteristics, previous medical history, lifestyle mea-
surements, current medical condition, baseline measure of the outcome and other
assessments. Some of these baseline covariates may be related to the primary
outcome and may exhibit chance imbalances between the two treatment groups.
There exists a vast literature on whether or not and how to adjust the analysis
of treatment difference for the effects of covariates. Two schools of thought exist on
the role of covariate adjustment. One, looking at the treatment comparison condi-
tional on the allocation of covariates, regards covariate adjustment as required to
characterize the potential benefit an individual might accrue from treatment, e.g.
Hauck et al. (1998) “recommend that the primary analysis adjust for important
prognostic covariates in order to come as close as possible to the clinically most
relevant subject-specific measure of treatment effect”. The other, a long-standing
idea originated with R.A.Fisher (1932), is concerned with the overall treatment
difference and sees the role of covariate adjustment as a means of increasing pre-
cision and thereby statistical power. There is no doubt that both conditional and
unconditional (on covariates) treatment effects are of considerable and complemen-
tary importance in developing a comprehensive understanding of how treatments
compare. Inference on the former can reveal interactions between treatment and
patient characteristics, which may have critical implications for use of the treat-
ment in certain subpopulations. The latter provides a measure of overall effect
useful for broad policy recommendations, which explains its role as primary focus
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of regulatory authorities.
With continuous outcome, the above debate rarely receives explicit mention
because (a) in randomized clinical trials the independence between the treatment
assignment and baseline covariates leads to the coincidence of the unconditional
and conditional treatment differences regardless of whether or not the regression
model between the outcome and covariates is correctly represented (b) the ad-
justed analysis is generally more precise than the competing methods which do
not take the covariates into account. Nevertheless, the conventional wisdom that
such unbiasedness and efficiency gains will also be achieved with respect to re-
gression models other than classical linear regression does not apply to all the
situations. On the one hand, Gail (1984) shows that the regression of the response
variable on treatment and covariates being linear or exponential is the sufficient
and necessary condition for the coincidence of the conditional and unconditional
treatment effects. On the other hand, unlike the classical linear regression case,
covariate adjustment in nonlinear regression models does not necessarily guarantee
the efficiency improvement, e.g. Robinson and Jewell (1991) prove that adjustment
for covariates always leads to a loss (or at best no gain) of precision in logistic re-
gression models (Mantel and Haenszel 1959; Mantel 1989). A similar point is also
made by Breslow and Day (1987).
The discrepancy between the adjusted and unadjusted analyses has inspired
considerable controversy among numerous researchers (Pocock et al. 2002; Ass-
mann et al. 2000; Raab et al. 2000; Senn 2000) and regulatory authorities (Lewis
1999; Grouin et al. 2004). Since covariate adjustment may involve a post hoc
selection of baseline covariates and different choices of covariates can lead to dif-
ferent treatment effects, analysts are often tempted to find “the covariate model
that best accentuates the estimate and/or statistical significance of the treatment
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difference” (Pocock et al. 2002). Thus, trialists and regulatory agencies are reluc-
tant to endorse adjusted analyses, and current guidelines assert strongly that, if
adjustment is undertaken, only a few such covariates should be used, chosen on the
basis of prior knowledge or their prognostic value; these should be prespecified in
the protocol or analysis plan, as should be the form of the model relating covariates
to outcome to be used for adjustment(Lewis 1999; Grouin et al. 2004). However,
associations between covariates and outcome may not be appreciated at the de-
sign stage (Pocock et al. 2002), particularly if such information was not collected
systematically in previous studies, but may be evident only at the analysis stage,
subsequent to unblinding. An unfortunate consequence of these recommendations
is that a critical opportunity to enhance the efficiency and reveal important real
effects may be lost.
To this end, it is desirable to find approaches that make best use of the baseline
data while supporting objective incorporation of covariate effects. In other words,
approaches that can obviate subjective modeling of the covariate-outcome relation-
ships while simultaneously exploiting these relationships to improve the precision
of treatment effect inference are needed. In the spirit above, an early develop-
ment that has drawn a great deal of interest was proposed by Koch et al. (1998).
Koch’s sampling-based method corrects for random imbalances for various types
of responses and designs and does not require regression modeling of covariates
effect. The resulting algorithm always reduces the variance and is computationally
straightforward through the application of weighted least squares. Nonetheless, a
general strategy for achieving the goal was not available until Tsiatis et al. (2008).
Based on some previous work in the literature of missing data problems by Leon
et al. (2003) and Davidian et al. (2005), Tsiatis et al. show that all unbiased
estimators for the overall difference in mean outcome between two groups can
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be obtained through augmenting the difference in sample means by an auxiliary
term. This characterization summarizes many familiar estimators, including AN-
COVA and Koch’s estimator, in a general framework, which facilitates comparison
among existing methods and provides insights into the precision improvement by
incorporating covariates. The general representation also allows us to identify the
most efficient estimator(which outperforms Koch’s estimator) and thus derive the
semiparametric efficiency bound.
In Chapter 2, we overview existing model-free methods and a more general ap-
proach by Zhang et al. (2008), based upon which we have developed an empirical
likelihood based method for nonparametric covariate adjustment. Emerging ele-
gantly from empirical likelihood theory developed by Owen (1988, 1990) and Qin
and Lawless (1994) is the proposed adjustment method that not only supports the
objective incorporation of baseline information but also reduces the computational
complexity caused by fitting a nonparametric regression, which is unavoidable in
the implementation of Tsiatis et al.(2008) and Zhang et al. (2008). More ideally,
the asymptotic variance of the maximum empirical likelihood estimator will be
monotone decreasing with more moment constraints and the semiparametric effi-
ciency bound can be achieved if the number of constraints grows to infinity. This
result is not only useful for nonparametric covariate adjustment but also broad-
ens the scope of the traditional empirical likelihood method, where the inferential
efficiency of the parameter of interest is well studied only under finitely many
constraints.
Addressing a different problem, Chapter 3 is also devoted to developing non-
parametric methods. In statistics, it is of fundamental interest to test whether two
data sets come from the same underlying distribution. In one dimension, one would
have little hesitation in using a rank based method, such as Kolmogorov-Smirnov
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and Crame´r-von Mises tests. A main ingredient in those tests has been the ranks
of the observations in the pooled sample. Since a monotone transformation can
make univariate data follow a uniform distribution on the unit interval while the
ranks remain invariant, the corresponding test statistics are distribution free under
the null hypothesis. However, there is no natural order on the multidimensional
space and therefore it is difficult to define a parallelism for “rank”. There exists
a rich literature extending the notion of ranking to multivariate cases, based on
the concepts of “data depth”. Early contributions include those of Tukey (1975),
Liu (1988,1990), Donoho and Gasko (1992), Du¨mbgen (1992) and Liu and Singh
(1992,1993). Nevertheless, to our knowledge, the multivariate two-sample problem
has never been connected with survival analysis. In Chapter 3, by converting the
original observations in the multivariate space into survival times, we construct a
class of intensity censored score processes under varied censoring schemes, which
give us power to detect the localized differences in nonlinear problems. In fact,
the proposed approach can easily be extended to functional spaces as long as a
reasonable distance measure can be introduced. When the sample size involved is
small, a permutation based test can be used to obtain the cutoff values. While
the sample size is large, we can employ a random weighting scheme which greatly
reduces the computational intensity. We close this dissertation by summarizing
Chapter 2 and 3 and discussing some future directions in Chapter 4.





Testing for the statistical significance of treatment differences is a key element
in the analysis of randomized clinical trials. In its simplest form, patients are
randomly allocated to either a treatment or control group and their responses
are recorded. Many statistical methods are available for testing whether there is
convincing evidence that a treatment difference exists between the two groups;
cf. Pocock (1983) and Friedman, Furberg and DeMets (1998). In addition to
treatment allocation and outcome values, baseline covariate information is often
collected in such clinical studies. Classical analysis of covariance (ANCOVA) and
other regression model-based tests may be used to handle covariate adjustment;
cf. Scheffe (1959), Simon (1984), McCullagh and Nelder (1989) and Rutter and
Elashoff (1994). When properly used, covariate adjustment can increase efficiency
and, in the case of an observational study, reduce bias (Armitage 1981).
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Due to randomization, most two-sample (multi-sample if more than two treat-
ment groups are involved) tests are valid without any parametric assumption.
Therefore, these tests are nonparametric in nature, a feature of great importance
in a clinical trial. Standard methods for covariate adjustment, however, require
that a specific regression model be assumed; see, for example, Piantadosi (2005,
Chapter 17).
Adjusting for covariates without assuming a regression model has been studied
by Koch (1998), Tsiatis, Davidian, Zhang and Lu (2008) among others. In partic-
ular, Koch (1998) proposed a weighted least squares method to include covariate
information for estimating the treatment difference. This method always leads to
a variance reduction, thus an increase in power. By appealing to semiparametric
efficiency theory, Tsiatis et al. (2008) developed a general approach to covariate
adjustment that circumvents modeling the covariate-outcome relationship. Their
approach allows for nonlinear terms in relating the auxiliary covariates to the out-
come variable, thereby further reducing the variability. They showed that the
method is semiparametrically efficient by deriving the semiparametric information
bound and by showing the bound is attained with their approach.
An essential ingredient in the approach by Tsiatis et al. (2008) is the use of
the independence of treatment assignment and baseline covariates to construct
estimating equations. These equations can be viewed as constraints that, when
properly utilized, may lead to further reduction in variability of the outcome vari-
able. How to optimally use these constraints is therefore crucial for efficiency
improvement.
Empirical likelihood (Owen 1988) is a general method for efficiently utilizing
constraints or estimating equations. Specifically, it maximizes the nonparamet-
ric likelihood (Kiefer and Wolfowitz 1956) subject to certain constraints that are
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specific to the problem of interest. It can be used to obtain empirical likelihood
ratio tests as well as confidence intervals. Examples include testing and interval
estimation for population means and for regression coefficients. Qin and Lawless
(1994) showed that the constraints can be used more liberally in the sense that the
number of constraints may exceed the number of parameters of interest. They also
showed that the empirical likelihood utilizes the information in the constraints in
an optimal way.
Because baseline covariate information for a randomized clinical trial generates
constraints, it is natural to consider the empirical likelihood as a means to improve
efficiency for the primary problem of testing and estimating treatment difference.
To that end, this chapter proposes a general approach to covariate adjustment by
making use of the empirical likelihood and suitably choosing constraints. The new
approach does not require any model assumption on the relationship between the
outcome variable and baseline covariates. It is shown that such an empirical like-
lihood based method automatically results in efficiency improvement. For testing,
it is asymptotically most powerful; for estimation, it achieves the semiparametric
information bound.
The rest of the chapter is organized as follows. In Section 2.2 we introduce some
notation. Section 2.3 and 2.4 briefly discuss existing model-based and model-free
methods, respectively. We apply the empirical likelihood method for covariate
adjustment and extend it to inference with an increasing number of constraints in
Section 2.5. The design and results of simulation studies are described in Section
2.6. In Section 2.7, the method is applied to a study of acute myocardial infarction.
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2.2 Notation and model specification
In a (K + 1)-arm (K ≥ 1) randomized clinical trial, for subject i, let Yi, Zi
and X i denote the outcome, treatment allocation and available auxiliary baseline
covariates, respectively. Assume that (Yi, Zi,X i), i = 1, . . . , n, are independent
and identically distributed (i.i.d.) and that the random allocation probabilities
pik = P (Z = k), k = 0, . . . , K, where
∑K
k=0 pik = 1, are known.
Throughout, Gk denotes the conditional distribution of the outcome variable
Y given treatment allocation Z = k, k = 0, . . . , K. Then the usual null hypothesis
of no treatment difference is given by
H0 : G
0 = G1 = . . . = GK .
Note that there is no assumption on the form of {Gk, k = 0, . . . , K}.
To study treatment effects, one may choose certain contrasts among the treat-
ment groups in terms of their population characteristics, for example, the difference
in mean outcomes between two treatment groups. Following Zhang et al. (2008),
the treatment effect can be identified by considering
β1 = E(Y |Z = 0), β2 = E(Y |Z = 1)− E(Y |Z = 0), (2.1)
or equivalently, by formulating
E(Y |Z) = β1 + β2Z. (2.2a)
Clearly, such an approach does not require model assumption on the underlying
distribution functions Gk, k = 0, . . . , K. If there are more than two treatment
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groups, equation (2.2a) becomes
E(Y |Z) = β1 + β21(Z=1) + . . .+ βK+11(Z=K), (2.2b)
where 1(·) is the indicator function and βk+1 represents the difference in mean
outcome between group k and group 0. For a binary outcome, an alternative
formulation is via the log-odds ratios:
logit{P (Y = 1|Z)} = log
{
P (Y = 1|Z)
P (Y = 0|Z)
}
= β1 + β21(Z=1) + . . .+ βK+11(Z=K).
(2.3)
Under this formulation, testing the null hypothesis of no treatment difference is
tantamount to testing H0 : β2 = . . . = βK+1 = 0, and estimating the treatment
effect is tantamount to estimating values of the βk, k = 2, . . . , K+1. For notational
convenience, we use β to denote the parameter vector (β1, . . . , βK+1)
T .
Besides the outcome variable and treatment assignment, relevant baseline co-
variates, which may comprise patients’ demographic information, medical history,
lifestyle measurements, etc., may be recorded as well. Their association with and
impact on the outcome variable can then be explored for efficiency gains in testing
and estimation of treatment effects.
2.3 Model-based covariate adjustment
A common approach to making use of the covariate information is to postulate a
certain regression model, which gives treatment comparisons conditional on values
of the covariates. Without loss of generality, we first assume the randomized clinical
trial is two-armed, i.e., Z = 1 or 0 with probabilities pi1 or 1 − pi1 and there is a
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single covariate X, which is related to the outcome Y . Randomization guarantees
statistical independence of Z and X.
2.3.1 Covariate inclusion in the linear model
If the outcome Y is continuous, consider the following two models:
Model 1 Y = β1 + β2Z + ε1, E(ε1) = 0, Var(ε1) = σ
2
1 (2.4)
Model 2 Y = β1 + β
∗
2Z + γX + ε2, E(ε2) = 0, Var(ε2) = σ
2
2. (2.5)
Model 2, usually called the “analysis of covariance” (ANCOVA) model, incorpo-
rates the covariate information by adding a linear term ofX in the linear regression
model 1. Because of the underlying linearity of the problem and the independence
of Z and X, the magnitude of the treatment effect in model 1, β2, is exactly the
same as that in model 2, β∗2 , which enables us to infer the unconditional treat-
ment effect using the conditional model. Besides, we have the following formulae
of variances:






Model 2 Var(βˆ∗2) = {σ22/
n∑
i=1
(zi − z¯)2}/[1− {corr(z, x)}2]
where z¯ = n−1
∑n
i=1 zi and corr(z, x) denotes the sample correlation coefficient
between the treatment assignment Z and the covariate X. The sample correlation
corr(z, x) should be close to zero because of randomization. Since the covariate X
is correlated with the outcome Y , there will be a reduction of residual variance,
i.e. σ22 will be less than σ
2
1. Consequently, the ANCOVA model improves precision
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in the linear regression case.
2.3.2 Covariate inclusion in the nonlinear model
The success of the ANCOVA model in preserving the unconditional treatment dif-
ferences as well as improving the precision gave rise to the popularity of regression
based covariate adjustments. However, conditional and unconditional treatment
effects are not always equal. In fact, there is a vast literature that examines in
what situations the magnitude of the treatment effect changes with the inclusion
of covariates. Even in randomized clinical trials with perfectly balanced covariates,
the conditional and unconditional effects may be unequal. This can be seen from
a simple hypothetical example. Suppose in a randomized clinical trial, half of the
patients are randomized to treatment A (Z = 1) and the other half to treatment B
(Z = 0). The outcome of interest Y is the survival status (Y = 0 for survival and
Y = 1 for death) 30 days after treatment. The data are summarized in Tables 2.1
and 2.2. The baseline covariate in consideration, gender (X), is fully balanced
between treatments A and B, but it is a strong predictor of the mortality rate.
In particular, 16% of the men died and 84% of the women died. Simple algebra
shows that the mortality rate odds ratio is 0.5 in both strata, but 0.7 in the whole
population. Since gender is dichotomous, the following two models are both valid.
logit{P (Y = 1|Z)} = β1 + β2Z (2.6)
logit{P (Y = 1|Z,X)} = β∗1 + β∗2Z + γX (2.7)
In the hypothetical example, the unconditional treatment effect estimate βˆ2 from
(2.6) is log(0.7) while the conditional estimate βˆ∗2 from (2.7) is log(0.5). In fact, Gail
(1984) demonstrates that “the asymptotic bias from omitting needed covariates is
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Table 2.1: Hypothetical example: by strata
Male: OR= 0.5 Female: OR= 0.5
Treatment Dead Survival Dead Survival
A 10 80 72 18
B 18 72 80 10
Total 28(16%) 152(84%) 152(84%) 28(16%)
Table 2.2: Hypothetical example: pooled
Total: OR= 0.7
Treatment Dead Survival Total
A 82 98 180
B 98 82 180
Total 180(50%) 180(50%)
zero if the regression of the outcome on treatment assignment and covariates is
linear or exponential, and, in regular cases, this is a necessary condition for zero
bias”.
According to Gail (1984), randomization leads to consistent treatment esti-
mates in a large number of nonlinear models, however, it excludes many important
ones such as logistic regression with binary data and Cox models with censored
data. For logistic regression, the conditional and unconditional treatment effect
estimates coincide when Z and X are conditionally independent given Y . In that
case, people tend to believe that adjustment for X will also improve the precision
in logistic models. Surprisingly, Robinson and Jewell (1991) demonstrate that ad-
justment for predictive covariates will always result in a loss of precision. Whereas
when testing for a treatment effect in randomized studies greater efficiency is still
achieved by adjusting for predictive covariates, just as for classic linear regression.
Lagakos and Schoenfeld (1984) and Morgan (1986) consider a related issue. They
find a loss of efficiency for the test of no treatment effect when covariates are
omitted from Cox regressions, with the magnitude of the loss increasing with the
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magnitude of the effect of the covariates. However, the regression parameters are
biased toward zero in the unconditional model, as compared with the Cox model
including covariates, and the bias depends on the amount of censoring.
In summary, regression based covariate adjustments lead to inconsistent esti-
mates when the regression of outcome on the treatment assignment and covariates
is not linear or exponential. Even though the estimates are consistent in some
circumstances, the conditional model may not necessarily improve precision.
2.4 Existing model-free methods
To make covariate adjustment completely objective, model-free adjustment ap-
proaches are needed. The aim is to efficiently utilize the baseline information to
estimate the unconditional treatment difference, without modeling of the relation-
ship between the outcome and covariates. In this section, we will outline two
existing methods meeting this goal.
2.4.1 Koch’s method
In pioneering work, Koch et al. (1998) constructed a consistent estimator of the
unconditional treatment effect that always reduces the asymptotic variance (rela-
tive to using the difference between means in the treatment and control groups).
The strategy therein can be used to compare continuous, ordinal and binary re-




i=1 Zi subjects are randomized to treatment (Z = 1) and n0 =∑n
i=1(1−Zi) subjects are randomized to control (Z = 0), n1+n0 = n. Let β denote
the difference in mean outcome between treatment and control. A natural estimate
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for β is the difference in observed average responses under treatment and control,
i.e., βˆunadj = y¯1 − y¯0, where y¯1 = n−11
∑n





The rationale for Koch’s method is based on a weighted least-squares procedure






















i=1(1− Zi)X i are the sample
averages of the covariate vectors for the treatment and control groups, respectively.
The treatment difference β is estimated with weights based on a consistent estimate





The resulting adjusted estimator of the treatment difference
βˆadj = y¯1 − y¯0 − vTyxv−1xx (x¯1 − x¯0). (2.8)
The asymptotic variance of βˆadj, vadj, is the limit of vyy − vTyxv−1xxvyx. Note that
vadj is never larger than the asymptotic variance of the unadjusted estimator vunadj,
which is the limit of vyy. Koch et al. also show that both the unadjusted test statis-
tic Qunadj = βˆ
2
unadj/vyy and the adjusted test statistic Qadj = βˆ
2
adj/(vyy−vTyxv−1xxvyx)
have a χ21 distribution under the null hypothesis that β = 0. Under the alterna-
tive hypothesis that the two means are different, Qunadj and Qadj have asymptotic
non-central χ21 distributions with non-centrality parameters β
2/vunadj and β
2/vadj,
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respectively. Thus this nonparametric approach increases the statistical power
through variance reduction; see Koch et al. (1998) for the details.
2.4.2 Semiparametric inference
A more general strategy achieving the goal of separating modeling of the covariate-
outcome relationship from evaluation of the treatment effect is elucidated by Tsiatis
et al. (2008). An original motivation for building a semiparametric framework is
to conceptualize inference on the treatment effect β as a “missing data problem”
(Leon et al. 2003). Ideally, if we could observe the outcome on each subject under
both treatment and control conditions, we would have complete sample information
on the treatment effect, which should lead to the most efficient inference. However,
this is not possible: for subjects randomized to treatment, the outcome they would
have if assigned to the control group is “missing”, and vice versa. Nevertheless,
randomization still enables a valid comparison. Hence, covariate adjustment may
be viewed as an attempt to use covariates that are correlated with the outcome
to recover the “missing” information to some extent and thus improve efficiency.
By making this analogy to missing-data problems and using the semiparametric
missing-data theory of Robins et al. (1994), Leon et al. (2003) and Davidian et al.
(2005) derive the class of all consistent estimators for β when one of the elements
of X is a baseline observation on Y .
2.4.2.1 A semiparametric framework
Following the notation in Section 2.4.1, let Z¯ = n−1
∑n
i=1 Zi denote the sample
proportion randomized to treatment. If we make no assumptions about the joint
distribution of (Y, Z,X) except that Z is independent of X, as implied by ran-
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domization, then it follows from Leon et al. (2003) and Davidian et al. (2005)
that all reasonable consistent and asymptotically normal estimators of β can be
expressed either exactly or are asymptotically equivalent to an expression of the
form
Y¯1 − Y¯0 −
n∑
i=1
(Zi − Z¯){n−11 h1(X i) + n−10 h0(X i)} (2.9)
where hk, k = 0, 1 are arbitrary scalar functions of X.
When h1(·) = h0(·) = 0, (2.9) reduces to the sample mean difference Y¯1 − Y¯0,
the standard unadjusted estimator. According to (2.9), all consistent and asymp-
totically normal estimators for β can be obtained by augmenting this standard
estimator by the second term, which incorporates the covariates. Since Z and X
are independent, the “augmentation” term converges in probability to zero for any
hk, so that the resulting estimators will always be consistent for β. Besides, varied
choices for hk provide insight into the nature of the improvement in precision.
2.4.2.2 Distinction and relative precision of common estimators
Tsiatis et al. (2008) demonstrate that many familiar estimators can be written in
the form of (2.9) asymptotically and thus are consistent for β. The least square
estimator for β∗2 in ANCOVA model (2.5), which we denote as βˆANCOV A1, is asymp-
totically equivalent to (2.9) with





ΣXY = E[{X − E(X)}{Y − E(Y )}] (2.11)
ΣXX = E[{X − E(X)}{X − E(X)}T ]. (2.12)
CHAPTER 2. NONPARAMETRIC COVARIATE ADJUSTMENT 19
Note that model (2.5) from which βˆANCOV A1 is derived need not be correctly
specified for E(Y |X, Z) in order for the above results to hold. In practice, we can
substitute the corresponding sample covariance matrices for (2.11) and (2.12) and
the resulting estimator will have the same asymptotic distribution as if (2.11) and
(2.12) were known. In general, replacing hk with their consistent estimators will
not affect the large sample properties.
From (2.10), hk, associated with βˆANCOV A1, are the same for k = 0, 1 and are
linear in X i. Define
Σ
(k)
XY = E[{X − E(X)}{Y − E(Y )}|Z = k], k = 0, 1. (2.13)




XY , (2.10) can be expressed equivalently as
h1(X i) = h0(X i) = {pi0Σ(0)XY + pi1Σ(1)XY }TΣ−1XXX i. (2.14)
Other popular estimators, linear inX, may also be written in the form of (2.9)
asymptotically, with h1 = h0. Consider another ANCOVA model including an
interaction term between Z and X, which can be expressed in a centered version
as
E{Y−E(Y )|Z,X} = γTX{X−E(X)}+γTXZ{X−E(X)}{Z−E(Z)}+βZ{Z−E(Z)}.
(2.15)
It can be fitted by least-squares regression of Yi − Y¯ on X i − X¯ and Zi − Z¯,
where Y¯ = n−1
∑n
i=1 Yi and X¯ = n
−1∑n
i=1X i. The least-squares estimator for
βZ , denoted as βˆANCOV A2, can be expressed in the form of (2.9) asymptotically
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with
h1(X i) = h0(X i) = {pi1Σ(0)XY + pi0Σ(1)XY }TΣ−1XXX i. (2.16)
Hence, βˆANCOV A2 is a consistent and asymptotically normal estimator for β2 in
(2.4) regardless of whether (2.15) is a correct representation for E(Y |X, Z).





XY . Otherwise, βˆANCOV A2 is more precise than βˆANCOV A1. In fact, βˆANCOV A2
has the smallest asymptotic variance among all the estimators for which hk(X i),
k = 0, 1, are linear in X i. In other words, estimators with hk (possibly different
for k = 0 and k = 1) linear in X i can not be more precise than βˆANCOV A2.
The estimate (2.8) proposed by Koch et al. (1998), here denoted as βˆKOCH ,
can easily be seen to have the form (2.9) by replacing vxy and vxx with their limits





















XY = (nk − 1)−1
n∑
i=1
1(Zi=k)(Yi − Y¯ (k))(X i − X¯(k))
Σˆ
(k)
XX = (nk − 1)−1
n∑
i=1
1(Zi=k)(X i − X¯(k))(X i − X¯(k))T
X¯1 − X¯0 = (n−10 + n−11 )
n∑
i=1
(Zi − Z¯)X i,
it can be shown that βˆKOCH is asymptotically equivalent to βˆANCOV A2. Conse-
quently, Koch’s estimator is asymptotically the most precise one among all the
estimators having hk linear in X i.
It is natural to ask if there are estimators that outperform these linear candi-
dates. By appealing to semiparametric theory or a direct argument (Tsiatis et al.
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2008), among all the estimators exactly equal to or asymptotically equivalent to
an expression of form (2.9), that with the smallest variance asymptotically has
hk(X i) = E(Yi|Zi = k,X i), k=0,1.
That is, the “optimal” hk, k = 0, 1, are the true regression relationships of Y onX
for the corresponding treatment group, which may not be linear inX. By virtue of
being in the form (2.9), failure to identify these true regression relationships will not
affect the consistency and asymptotic normality of the corresponding estimators
and their asymptotic variances will usually be smaller than that of the unadjusted
estimator.
2.4.2.3 Generalized framework
The above framework for comparing two mean outcomes can be extended to general
measures of treatment effects, such as an odds ratio associated with a binary
outcome, a hazards ratio associated with a censored time-to-event outcome and
so on. Let β denote the q-vector of parameters involved in making treatment
comparisons under the marginal model between Y and Z (e.g. log-odds ratio)
and let m(β;Y, Z) be the corresponding q-vector of estimating equations which
usually has been well studied and leads to a consistent and asymptotically normal
estimator, unadjusted for covariates (see Section 2.5.2 for more details). In the
same spirit, the estimator for β with the smallest asymptotic variance can be




(1{Z=g} − pig)E(m(β;Y, Z)|Z = g,X). (2.17)
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See Zhang et al. (2008) for detailed derivations.
The optimal estimator from solving a sample version of (2.17) depends on the
form of the conditional expectations
E(m(β;Y, Z)|Z = g,X), g = 0, . . . , K, (2.18)
which are unknown. Although we have argued that falsely specifying the true
regression relationships won’t affect the consistency and asymptotic normality, we
do hope to postulate a regression model as close as possible to (2.18) to achieve
optimality. To that end, the following adaptive strategy is proposed in Zhang et
al. (2008).
1. Solve the original estimating equations
∑n
i=1m(β;Yi, Zi) = 0 to obtain the
unadjusted estimator βˆun. For each subject i, obtain the valuesm(βˆun;Yi, g)
for each g = 0, . . . , K.
2. For each g and for each component of the q-vector m(βˆun;Yi, g), develop a
parametric regression model
E{mu(βˆun;Y, Z)|X, Z = g} = rgu(X, ζgu), u = 1, . . . , q,
where m = (m1, . . . ,mq)
T . The regression models rgu(X, ζgu) are repre-
sented as cgu(X)
Tζgu, u = 1, . . . , q, where cgu(X) are vectors of basis func-
tions in X that may include polynomial terms, splines, interactions, etc.
and ζgu are the coefficients. Let rg(X, ζˆg) denote the vector of prediction
values of the conditional expectations (rg1(X, ζˆg1), . . . , rgq(X, ζˆgq))
T , where
ζˆg = (ζˆg1, . . . , ζˆgq) are the least-squares estimates for ζg = (ζg1, . . . , ζgq).
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{1(Z=g) − pig}rg(X i, ζˆg)
]
= 0 (2.19)
and solve for β to obtain the adjusted estimator.
Undoubtedly, approaches that can avoid fitting nonparametric regressions while
achieving the semiparametric efficiency are highly desirable. Thus, the empirical
likelihood method, which is not only nonparametric and constraint-based but can
automatically summarize data in the most efficient way as well, becomes a natural
and promising candidate to meet all the needs.
2.5 Empirical likelihood based methods for non-
parametric covariate adjustment
This section is devoted to the development of an empirical likelihood based method
for nonparametric covariate adjustment arising from a typical randomized clinical
trial. To begin with, Section 2.5.1 reviews some basic concepts and results from
empirical likelihood, upon which the contributions herein are made. Section 2.5.2
develops an empirical likelihood ratio based test and establishes its asymptotic
properties. The subsequent subsection deals with the dual problem of estimating
treatment effects via maximizing the empirical likelihood when the number of
constraints exceeds the number of parameters. Section 2.5.4 extends the results of
§2.5.2 and §2.5.3 to the situation in which the number of constraints increases with
the sample size. Asymptotic normality and Wilks type χ2 approximations as well
as asymptotic efficiency are established for all the cases under suitable regularity
conditions.
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2.5.1 Background
2.5.1.1 Definition
Being first implicitly used in Thomas and Grunkemeier (1975), empirical likelihood
was developed into a general methodology by Owen (1988, 1990). Given W i,
i = 1, . . . , n, assumed to be independent with a common cumulative distribution
function (CDF) F0, the empirical likelihood function is a nonparametric likelihood








where wi is the observed value of W i, pi = dF (wi) = P (W i = wi), i = 1, . . . , n.





Without additional constraints, it is well known that the empirical distribution
function is the nonparametric maximum likelihood estimate of F0, denoted as Fn,
or pi are estimated to be all equal to n









Note that the formulae here and elsewhere in this dissertation do not require that
the observations W i, i = 1, . . . , n, are distinct.
CHAPTER 2. NONPARAMETRIC COVARIATE ADJUSTMENT 25
2.5.1.2 Empirical likelihood with moment constraints
Most empirical likelihood problems are concerned with estimating or testing for a
parameter µ associated with F , with µ defined through moment constraints, or,
estimating equations. Below we walk through a simple but illuminating example, in
which the mean µ of F is considered. Although this example seems oversimplified,
it is straightforward to extend the methodology illustrated there to more general
cases.
To obtain confidence regions for µ, we incorporate the first order moment











pi(wi − µ) = 0
}
. (2.21)
As noted by Owen(1988,1990), a unique value for the right-hand side of (2.21)
exists, provided that µ is inside the convex hull of the observations w1, . . . ,wn.








Since L(F ) is maximized at Fn, it follows that LE(µ) is maximized at µˆ = w¯ =
n−1
∑n
i=1wi and pi = n
−1. Using a Lagrange multiplier argument (see the next
part for details), the maximum for the numerator is attained when
pi = pi(µ0) = n
−1{1 + λT (wi − µ0)}−1,
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where λ = λ(µ0) is the solution to
n∑
i=1





{1 + λT (wi − µ0)}−1





log{1 + λT (wi − µ0)}.
Owen (1988,1990) has proved under mild conditions that under the null hypothesis
H0, the empirical likelihood ratio statistic TE(µ0) converges in distribution to a χ
2
random variable with q (=dim(µ0)) degrees of freedom as n goes to infinity. Hence,
approximate α-level confidence regions for µmay be obtained as the set of points µ
such that TE(µ) ≤ cα, where cα is defined such that P (χ2q ≤ cα) = α. Similarly, the
profile empirical likelihood ratio statistic can also be used to construct confidence
regions for subsets of µ. With an arbitrary parameter µ defined through estimating
functions Eg(µ;w) = 0, we simply replacewi−µ0 in the above steps with g(µ;wi)
and all the results still hold.
2.5.1.3 A two-stage Newton algorithm
Maximizing the empirical likelihood function is a constrained optimization prob-











pi − 1), (2.22)
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where λ and γ are Lagrange multipliers. In this primal problem, the parameters
are pi, i = 1 . . . , n, µ, λ and γ. Since empirical likelihood is a nonparametric
likelihood, the number of parameters is essentially infinite. Setting the derivatives


















pi − 1 = 0. (2.25)



















By (2.26), the log-empirical likelihood function lE(µ) can be written as
lE(µ) = − log[n{1− λTg(µ;wi)}], (2.28)
which is a function of µ and λ only. To obtain the maximum empirical likelihood
estimator for µ, a two-stage Newton algorithm is commonly used. In the first
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stage, we fix µ at some initial value and solve for λ from (2.27). Note that this
is equivalent to a dual approach, in which we minimize lE with respect to λ. The
dual approach is a convex problem in two ways. First, the Hessian matrix of lE










{1− λTg(µ;wi) ≥ 0}
is the intersection of n hyperplanes, which is nonempty because λ = 0 is always in
it. Due to the convex duality, it is fast and robust to solve for λ when µ is fixed.
The dual approach not only reduces the dimensionality of the primal problem
by writing the likelihood function in terms of a finite number of parameters, it
also sheds light on the underlying structure of the Lagrange multiplier approach.
In fact, the Lagrange multiplier λ is the nuisance score in the semiparametric
framework. In the second stage, we fix λ at its obtained value from the first stage
and maximize (2.28) to solve for µ, then iterating the two-stage process until
convergence. Since the Hessian matrix of lE with respect to µ is not necessarily
negative definite, the resulting algorithm is not robust. To that end, modern
optimization techniques developed to tackle the computational issues in empirical
likelihood optimization are further discussed in Section 2.6.
2.5.2 Testing treatment differences
Empirical likelihood methodology for inference is based on maximizing the non-
parametric likelihood (2.20) subject to appropriately formulated and problem-
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specific constraints. For the two-arm randomized clinical trial specified by (2.2a),
the constraints are generated by
m(β;Y, Z) = (1, Z)T (Y − β1 − β2Z). (2.29a)
For general K specified by (2.2b), it becomes
m(β;Y, Z) = (1, 1(Z=1), . . . , 1(Z=K))
T (Y − β1 − β21(Z=1) − . . .− β(K+1)1(Z=K)).
(2.29b)
The zero-mean property ofm(β;Y, Z) uniquely determines the value of β and can
be used to obtain estimators through the sample-generated estimating equations.
The resulting inference involves only the Yi and Zi.
The availability of baseline covariates X i should enable us to obtain addi-
tional estimating equations, thereby additional constraints. Indeed, Davidian et
al. (2005) and Leon et al. (2003) found that the following form gives a general
family of estimating equations:
K∑
k=0
(1(Z=k) − pik)hk(X), (2.30)
where hk, k = 0, 1, . . . , K are arbitrary functions. The independence of Z and X
guarantees the zero-mean property of the resulting estimating equations.
It is clear now that the number of zero-mean estimating equations as provided
by (2.29) and (2.30) exceeds the number of parameters which specify the treatment
effect. In fact, the number of possible equations that can be generated from (2.30)
can be unlimited when the baseline covariates X are continuous. Suppose we fix
the choice of hk and consider how to make use ofX for efficiency improvement. For
CHAPTER 2. NONPARAMETRIC COVARIATE ADJUSTMENT 30
notational simplicity, we use gr(β;Y, Z,X) to denote an r-vector of the resultant
estimating equations that include both (2.29) and (2.30). Here r ≥ 2 in the two-
sample case and r ≥ K + 1 for the general (K + 1)-sample case.
It is well known that the empirical likelihood approach links inference for certain
parameters and the available estimating equations to form a constrained optimiza-
tion problem. With constraints given by gr, L(F ) is maximized in (2.20) subject







pigr(β;Yi, Zi,X i) = 0. (2.31)
This optimization problem has a unique maximizer provided that 0 is inside the
convex hull of {gr(β; yi, zi,xi), i = 1, . . . , n} for a given β (Owen 2001). By ap-
plying the Lagrange multiplier argument (Lang 1987), we can easily get pi =























Theorem 2.5.1. Let βT = (βT1 ,β
T
2 ), where β1 and β2 are q1- and q2-vectors.
Define
TE = 2lE(β̂10, 0)− 2lE(β̂), (2.34)
the logarithmic empirical profile likelihood ratio for testing H˜0 : β2 = 0, where β̂10
minimizes lE(β1, 0) with respect to β1 and β̂ minimizes lE(β). Then, under some
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mild regularity conditions, TE converges to a χ
2
(q2)
random variable in distribution
under H˜0.
Theorem 2.5.1 is a direct adaptation of Corollary 5 in Qin and Lawless (1994).
It enables us to get the p-value in testing the null hypothesis of no treatment
difference and to invert the test to obtain the confidence limits. A numerical way
to find β̂, and similarly for β̂10, is to use a two-stage Newton algorithm. We first
specify an initial value β(0) for β and solve (2.32) to obtain λ̂(β(0)). Next, we fix
λ̂(β) in (2.33) at λ̂(β(0)) and minimize (2.33) over β to obtain a new value β(1).
We iterate the process until convergence.
From Qin and Lawless (1994), it follows that the empirical likelihood ratio test
incorporating covariate information through constraints gr(β;Y, Z,X) is always
more powerful than the one withm(β;Y, Z) only. Moreover, the more constraints
we put into gr, the more powerful the test becomes. Because the net effect of the
empirical likelihood method with more constraints than parameters is an optimal
linear combination of the constraints, additional constraints should be chosen so
as to avoid redundancy. However, it is not necessary to model the relationship
between the covariates and the outcome, as is evident from equation (2.30); this
is a very desirable feature with important practical implications.
For a binary outcome variable, if we are interested in using the log-odds ratio,
then we can replace (2.29b) with
m(β;Y, Z) = (1, 1(Z=1), . . . , 1(Z=K))
T [Y − φ(β1 + β21(Z=1) + . . .+ β(K+1)1(Z=K))],
where φ(·) = exp(·)/[1 + exp(·)] is the logistic function. We can then follow the
same steps to construct the empirical likelihood ratio test. As before, the large
sample properties given by Theorem 3.1 continue to hold.
CHAPTER 2. NONPARAMETRIC COVARIATE ADJUSTMENT 32
2.5.3 Maximum empirical likelihood estimate of treatment
effect
Without adjusting for baseline covariates, the number of estimating equations,
derived from the score functions, equals the number of parameters. Solving equa-
tions
∑n
i=1m(β;Yi, Zi) = 0 gives us the M-estimator for β, which is known to be
consistent and asymptotically normal (Huber 1981). With covariate adjustment,
we have additional estimating equations containing auxiliary information through
(2.30). Since the number of all available estimating equations r exceeds the number
of parameters q = q1+ q2, we cannot obtain the estimators simply by finding zeros
of those estimating equations. One way to handle the additional constraints is
to form q-dimensional linear combinations of all available estimating equations so
that the resulting set of equations has a unique solution. One can further evaluate
the limiting covariance matrix of the estimator to identify the optimal choice of
such linear combinations; cf. Goldambe and Heyde (1987). Because the empirical
likelihood method with overly constrained estimating equations can result in the
optimal combination (Qin and Lawless 1994), it provides a natural alternative.
The following result follows directly from Qin and Lawless (1994).
Theorem 2.5.2. Let Dr = E[∂gr(β0)/∂β
T ] and Σr = E(grg
T
r ). Then, under
certain regularity conditions, we have








where β̂ is the maximum empirical likelihood estimate (MELE).
The theorem above allows us to construct Wald-type confidence intervals using
the robust variance estimate. From Corollary 2 of Qin and Lawless (1994), it fol-
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lows that β̂ has the smallest asymptotic variance among all the q-dimensional linear
combinations of gr(β;Y, Z,X). In particular, when r = q, the maximum empirical
likelihood estimator β̂ will be asymptotically equivalent to the M-estimator. Fur-
thermore, Corollary 1 of Qin and Lawless (1994) ensures that the more constraints
being put into the optimization problem, the more precision one can achieve.
As an example, consider again a two-arm clinical trial with a binary outcome
variable and a continuous covariateX, and suppose the log-odds ratio is of interest.
We can incorporate both linear and quadratic terms of X by using constraints
gr(β;Y, Z,X) =
(
(1, Z)[Y − φ(β1 + β2Z)], (Z − pi1), (Z − pi1)X, (Z − pi1)X2
)T
.
The resulting estimator will be more efficient than the M-estimator from (1, Z)T [Y−
φ(β1 + β2Z)]. Note that, for regression model based covariate adjustment, Robin-
son and Jewell (1991) demonstrated that including predictive covariates in the logit
will always result in a loss of precision. In contrast, for our empirical likelihood
approach, including predictive covariates in the constraints will never lead to an
increase in the asymptotic variance. The fact that incoporating additional estimat-
ing equations always improves efficiency makes the empirical likelihood approach
advantageous and convenient.
2.5.4 Empirical likelihood with an increasing number of
constraints
Since we can achieve more precision by increasing the number of constraints, it
is intuitive that semiparametric efficiency may be attained when the number of
constrains grows with the sample size. In this connection, we consider in this
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subsection empirical likelihood based covariate adjustment when the number of
constraints grows to infinity as n→∞. Note here that the dimension of β, which
is of primary concern, remains fixed.
Suppose besides the q-dimensional score m(β;Y, Z), the auxiliary information
is contained in an rn-vector of estimating equations g
∗
rn(β) = (m
T (β;Y, Z),V Tn )
T .
Instead of a fixed number r, rn here will grow to infinity with n at a certain rate.
The jth component of V n has the form (1(Z=k) − pik)hj(X) for j = 1, . . . , rn − q,
where hj is a real-valued function. The following conditions will be used.
(C1) There exists a non-random (rn − q)× (rn − q) matrix W n such that (i)-(iii)
below are satisfied for grn(β) = (m
T (β;Y, Z), (W nVn)
T )T .
(i) Components of gn,i, i = 1, . . . , n, are uniformly bounded by a finite constant
M > 0, where gn,i(β) = grn(β;Yi, Zi,X i).
(ii) Eigenvalues of Σn,g = E(grn(β0)g
T
rn(β0)) are bounded away from zero and
infinity.
(iii) There exists a q × (rn − q) non-random matrix An such that
AnW nV n →
K∑
k=0
(1(Z=k) − pik)E(m(β;Y, Z)|Z = k,X) in L2.
(C2) The growth rate of rn is limited to r
3
n = o(n).




(1(Z=k) − pik)E(m(β;Y, Z)|Z = k,X).
Throughout, ‖·‖ is used to denote the Euclidean norm. For notational conve-




∥∥gn,i(β)∥∥ , Drn = E(∂grn(β0)/∂βT ),
Dmn = E(∂mrn(β0)/∂β












Lemma 1. The probability that zero is outside the convex hull spanned by {gn,i, i =
1, . . . , n} goes to zero as n→∞.
Proof. This follows from Lemma 4.2 in Hjort et al. (2009) and discussions thereof.
Lemma 2. Under (i),(ii) and C2, the eigenvalues of Sn(β0) are bounded away
from 0 and ∞.
Proof. It can be shown by making use of proofs of condition (D4) and Lemma 4.5
in Hjort et al. (2009).
Lemma 3. Under (i),(ii) and C2,
∥∥∥λ̂n(β0)∥∥∥ = Op(n−1/2r1/2n ) (2.36)
sup
‖β−β0‖≤n−1/3
∥∥∥λ̂n(β)∥∥∥ = Op(n−1/3) (2.37)
sup
‖β−β0‖≤n−1/3
∥∥∥λ̂n(β)− Sn(β)−1g¯n(β)∥∥∥ = Op(n−2/3r1/2n ). (2.38)
Proof. Under (i),(ii) and C2, we can apply results in Portnoy (1988) to get
∥∥n1/2g¯n(β0)∥∥ = Op(r1/2n ). (2.39)
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Under (i),
Gn(β) ≤Mr1/2n = Op(r1/2n ). (2.40)
Write λ̂n(β) =
∥∥∥λ̂n(β)∥∥∥un(β), where ‖un(β)‖ = 1. Then similarly to (2.32), we
can show that













wheremineig(M) stands for the minimum eigenvalue of the matrixM . Therefore,
we have
∥∥∥λ̂n(β)∥∥∥ (mineig(Sn(β))− uTn (β)g¯n(β)Gn(β)) ≤ uTn (β)g¯n(β), (2.41)
from which we know that (2.36) holds due to (2.39), (2.40) and Lemma 2.
When ‖β − β0‖ ≤ n−1/3, define
Ln = max
j,k
|Sn,j,k(β)− Sn,j,k(β0)| . (2.42)
Using the same technique as in Lemma 2, rnLn = op(1) ensures that the minimum
eigenvalue of Sn(β) is bounded away from zero. Since there are only finitely many
terms in grn containing β, due to the δ-method, this can be further reduced to
‖β − β0‖ = o(r−1n ), which is true under C2. By expanding g¯n(β) in the n−1/3
neighborhood of β0, we obtain g¯n(β) = Op(n
−1/3) uniformly in ‖β − β0‖ ≤ n−1/3.
Then (2.37) follows from equation (2.41).






n (β)gn,i(β)} = 0,

















By the triangle inequality and some simple algebra, the final term in (2.43) is
bounded by Op(n
−2/3r1/2n ). Since ‖Sn(β)−1‖ = Op(1), (2.38) follows from (2.43).
Lemma 4. Under Conditions C1-C3,
∥∥∥DTrnΣ−1n,gDrn −DTmΣ˜−1Dm∥∥∥ = o(1).









which by (iii), converges to DTmΣ˜
−1
Dm.








wheremoptrn = Aopt(β)grn is a q-vector and Aopt(β) is the optimal linear combina-
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By Zhang et al. (2008), we know that DTmΣ˜
−1
Dm is the semiparametric efficiency
bound, which implies the first difference is non-positive definite. Since the second
difference is op(1), we know (2.45) is nonpositive definite.
Lemma 5. Under (i), (ii) and C2,
∥∥∥β̂n − β0∥∥∥ < n−1/3.
Proof. We first consider β on the n−1/3 sphere of β0, i.e. β− β0 = un−1/3, where

















By (2.38), this is equivalent to ng¯Tn (β)S
−1
n (β)g¯n(β) + Op(r
1/2
n ). By taking the






which is bounded below byOp(n









= Op(rn), which is strictly less than Op(n
1/3) by condition C2.
Therefore,
∥∥∥β̂n − β0∥∥∥ < n−1/3.
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Proof. We can reduce the problem to the unidimensional case by noting that it












Dmt by Lemma 4.





























where the last step comes from
P
( ∣∣tTDTrnΣ−1n,ggrn(β0)∣∣ > n1/2ε) ≤ E(tTDTrnΣ−1n,ggrn(β0))2/nε2,
which goes to 0 since the numerator is asymptotically bounded. Hence Lemma 6
holds by the Lindeberg-Feller Central Limit Theorem.
Theorem 2.5.3. Let β̂n be the maximum empirical likelihood estimate based on
constraints g∗rn(β) and Dm = E(∂m(β0)/∂β
T ). Then, under Conditions C1-C3,


















. We know that
(β̂n, λ̂n) satisfies Un(β̂n, λ̂n) = 0 and V n(β̂n, λ̂n) = 0. By taking the Taylor series
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expansion, we have
0 = Un(β̂n, λ̂n)
= g¯n(β0) + Dˆ
T
(β0)(β̂n − β0)− Sn(β0)λ̂n +Op(n−2/3r1/2n ), and(2.48)





Solving (2.48) and (2.49) for β̂n − β0, we get,
n1/2(β̂n − β0) = −n1/2(Dˆ(β0)TS−1n (β0)Dˆ(β0))−1Dˆ(β0)S−1n (β0)g¯n(β0) + op(1).
(2.50)
Using the triangle inequality and Lemma 4, we can show that

















Then Theorem 2.5.3 follows from (2.50), (2.51) and Slutsky’s Theorem.
Minimizing the asymptotic variance of the M-estimator from the class of ar-
bitrary q-dimensional unbiased estimating equations, Zhang et al. (2008) derived
the semiparametric efficiency bound for the estimators of treatment effect. From
Zhang et al. (2008) and Theorem 2.5.3, we have the following result.
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achieves the semiparametric efficiency bound, i.e., β̂n in Theorem 2.5.3 is asymp-
totically efficient.
In practice, in order to construct the Wald type confidence interval for β0,
we need to estimate the asymptotic variance expressed in (2.47). Let g¯n(β) =
n−1
∑n




n,i(β) and Dˆ(β) = ∂g¯n(β)/∂β
T .
Theorem 2.5.5 below shows that a consistent estimate of the limiting variance-
covariance matrix of n1/2(β̂n − β0) is [Dˆ(βˆn)S−1n (β̂n)Dˆ(βˆn)]−1.
Theorem 2.5.5. Under Conditions C1-C3,
∥∥∥Dˆ(βˆn)S−1n (β̂n)Dˆ(βˆn)−DTmΣ˜−1Dm∥∥∥ =
op(1).
Proof. Since there are only finitely many terms in g¯n and Sn that contain β, by
the δ-method, we have
∥∥∥(DˆT (β̂n)S−1n (β̂n)Dˆ(β̂n))−1 − (DˆT (β0)S−1n (β0)Dˆ(β0))−1∥∥∥ = op(1).
Then the result follows from (2.51).
Theorem 2.5.3 states that the listed conditions are sufficient to ensure standard
asymptotic properties of the MELE. Moreover, Corollary 2.5.4 states that when
the number of constraints grows to infinity at a certain rate, the MELE achieves
the semiparametric efficiency bound as derived in Zhang (2008). In Theorem 2.5.3,
grn is essentially a linear transformation of g
∗
rn . Since a linear transformation does
not change the constraints, the estimator using grn will be the same as that using
g∗rn . The fact that the MELE will not be affected by a linear transformation
of the constraints greatly facilitates the applicability of the empirical likelihood
approach because we can just throw in all the constraints we have without forming
the appropriate combination of them. For example, E[g∗rn(g
∗
rn)
T ] might be ill
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conditioned but we can still use it as long as there exists a W n such that the
corresponding Σn,g is better conditioned. For this reason, we will not distinguish
among linear transformations of constraints in the following discussion.
Theorem 2.5.3 holds for a general q-dimensional scorem as long as some regu-
larity conditions in the case of fixed number of constraints (Qin and Lawless 1994)




is of full rank p,
∥∥∂m(β;Y, Z)/∂βT∥∥
and
∥∥∂2m(β;Y, Z)/∂β∂βT∥∥ can be bounded by some integrable function in a
neighborhood of β0 and ∂m(β;Y, Z)/∂β and ∂
2m(β;Y, Z)/∂β∂βT are continu-
ous in this neighborhood.
Condition C2 imposes an upper bound on the growth rate of the number of
constraints at which a well-behaved MELE can be obtained. In practice, the
number of constraints need not be large. In fact, we find that additional gain
by including an extra constraint diminishes quickly, due to the optimal use of
constraints by the empirical likelihood method. It is important to note that the
asymptotic normality and efficiency are not affected by the choice of rn, as long as
C2 is satisfied. It is certainly of theoretical interest to find the sharp upper bound
for rn to grow such that the resulting estimate is still asymptotically normal and
efficient. But we will not get into this complication here since finding the optimal
rate is not our main concern. If we knew the conditional expectations in Condition
C3, the optimal estimating equations m˜ would be the constraints that lead to
the optimal estimator. Although they are unknown in practice, it is clear that
Condition C3 is fairly mild.
For Condition C1, we need to make use of the orthogonality and bounded-
ness of certain basis functions to properly design h(X) in the constraints. Sup-
pose Z = 0, 1, 2 and the empirical CDF of the one dimensional auxiliary co-
variate X is Fn(x) = n
−1∑n
i=1 1{Xi≤x}. By making use of multivariate Fourier
CHAPTER 2. NONPARAMETRIC COVARIATE ADJUSTMENT 43
expansion, the arguments can be generalized to the high dimensional auxiliary
covariate case. Let g∗rn(β) = (m
T (β;Y, Z), (11 − pi1), ŝ11, ĉ11, . . . , ŝ1dn , ĉ1dn , (12 −
pi2), ŝ21, ĉ21, . . . , ŝ2dn , ĉ2dn)
T , where 1k = 1(Z=k), rn = 4dn + q + 2, ŝij = (1i −
pii) sin(2pijFn(X)), ĉij = (1i − pii) cos(2pijFn(X)), i = 1, 2, j = 1, . . . , dn. It can
be shown that, when dn = o(n
1/4), (i)-(iii) are satisfied. For example, we can
apply the fact that those basis functions are orthogonal when their arguments are
U [0, 1] and they are bounded to show (i) and (ii) hold. Because the procedure
is invariant under linear transformations, the eigenvalues can grow with n if all
of them grow at the same rate. However, we do not believe in general they can
grow at different rates since the covariance matrix is sandwiched in the variance-
covariance expression, which needs to be well-conditioned. Furthermore, (iii) can
be verified by taking the expansion of the conditional expectations. Likewise, we
may apply other orthogonal basis functions that are bounded. For example, we
can use the Legendre polynomials of (2Fn(X) − 1) which are bounded by 1 on
[-1,1]. Legendre polynomials, i.e. 1, x, (3x2 − 1)/2, . . ., are linear transformations
of polynomial terms 1, x, x2, . . .. Therefore we can also use polynomial terms of
(2Fn(X) − 1) in the auxiliary constraints due to linear transformation invariance
of the empirical likelihood. Note that the standard independence assumption for
empirical likelihood is violated due to the plug-in estimator Fn. Intuitively, the
validity of using Fn instead of F relies on the fact that those constraints are still
zero-mean conditioning on all the covariates. A rigorous proof is provided below.
Proof. We verify that g∗rn in the examples following Corollary 2.5.4 satisfies Con-
dition C1. The other conditions are satisfied trivially. Since the Fourier basis
functions are naturally bounded by 1, the uniform boundedness reduces to the
boundedness of m which is of finite dimension and usually holds. So (i) is satis-
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fied. Let
V n = ((11 − pi1)/pi1, s11, c11, . . . , s1dn , c1dn , (12 − pi2)/pi2, s21, c21, . . . , s2dn , c2dn)T
and grn(β) = (m
T (β;Y, Z),V Tn )





2(1i − pii) cos(2pijF (X))/pii, i = 1, 2, j = 1, . . . , dn. For notational simplic-
ity, we omit W n in W nV n when there is no ambiguity. Then letting Id denote
the d× d identity matrix, we have the following matrix partition
Σn,g =






T ) −I2dn+1 1−pi2pi2 I2dn+1
 .
Thus, by some simple algebra and C3, we can show that the eigenvalues of Σn,g
are bounded away from 0 and ∞. However, since F is unknown in practice, we
typically use Fn(x) = n
−1∑n
i=1 1{Xi≤x} instead. Let
V̂
T
n (z, x) = ((11− pi1)/pi1, ŝ11, ĉ11, . . . , ŝ1dn , ĉ1dn , (12− pi2)/pi2, ŝ21, ĉ21, . . . , ŝ2dn , ĉ2dn)
and ĝrn(β) = (m
T (β;Y, Z), V̂
T
n (Z,X))
















Following the argument in Lemma 2, when we let rn = o(n
1
4 ), we know the eigen-
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values of E(ĝrn(β0)ĝ
T
rn(β0)) are also bounded away from zero and infinity. So (ii)
holds.
Moreover, let f(z, x) =
∑K
k=0(1k − pik)E(m(β;Y, Z)|Z = k, x) and An be the
Fourier coefficients in the Fourier expansion of f(z, x) with the Fourier basis speci-
fied in V̂ n(z, x). We know from Fourier approximation theory that AnV̂ n(z, x)→
f(z, x) uniformly. Thus, by Condition C3 and the Dominated Convergence Theo-
rem, (iii) is satisfied.
Proof of the validity of the plug-in estimator Fn. Checking the derivation of all
the theorems, we find that the following two conditions will guarantee the validity











}∥∥∥∥∥ = op(1), (2.53)
where gn,i and gˆn,i are grn and gˆrn evaluated at the i
th sample. The norm of a
matrix M is defined to be sup
u
‖Mu‖, where u is a unit vector. The sufficiency
of the above two conditions when the number of constraints is fixed can be seen
from the existing literature (see, for example, Hjort et al. (2009)).







}2∣∣∣∣X1, . . . ,Xn] ≤ C1r2n ‖Fn − F‖2∞ ,







2 ∣∣∣∣X1, . . . ,Xn} ≤ C1r3n ‖Fn − F‖2∞ = Op(r3n/n),
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which converges to 0 in probability due to C2. By Chebyshev’s inequality, we know







∣∣∣∣X1, . . . ,Xn} = op(1),
which implies (2.52) due to the dominated convergence theorem.








u. Then we have E{(εju)2|X1, . . . ,Xn} ≤
Op(r3nn
−2) uniformly for u and j. Therefore, E{‖εu‖2 |X1, . . . ,Xn} ≤ Op(r4nn−2) ≤
op(1), which implies (2.53).









. The empirical likelihood ratio statistic for testing H0 : β = β0 is
T1n = 2l(β0)− 2l(β̂n). (2.54)
Then under Conditions C1-C3, the Wilks type theorem of convergence to the χ2
distribution is still valid for testing the null hypothesis of no treatment effect.
Theorem 2.5.6. Suppose that Conditions C1-C3 are satisfied. Then, under the
null hypothesis H0, T1n converges in distribution to a χ
2
(q) random variable as n→
∞.
Proof. Taking the Taylor series expansion, we get













n1/2(β̂n − β0) + op(1)
= n1/2(β̂n − β0)TAn1/2(β̂n − β0) + op(1).
Then Theorem 2.5.3 implies T1n → χ2q as n→∞, when H0 is true.
More generally, we can test hypotheses concerning a subset of treatment effects
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β. For instance, we may be interested in testing whether β2 = 0 in the simple
example (2.2a). Specifically, let βT = (βT1 ,β
T
2 )
T , where β1 and β2 are q1- and
q2-vectors, respectively. For H˜0 : β1 = β10, the profile empirical likelihood ratio
test statistic is simply
T2n = 2l(β10, β̂20)− 2l(β̂n), (2.55)
where β̂20 minimizes l(β10,β2) with respect to β2. The following result shows that
a Wilks type χ2 approximation still holds.
Corollary 2.5.7. Suppose that Conditions C1-C3 are satisfied. Then, under the
null hypothesis, T2n converges in distribution to a χ
2
(q1)
random variable as n→∞.
Proof. When only β1 is specified in the null hypothesis, we write the likelihood
ratio statistic as the sum of two differences, each of which can be expanded in a







































n (β10, β̂20)gn,i(β10, β̂20)
)]
= n1/2(β10 − β̂1n)T (A11 −A12A−122 A21)n1/2(β10 − β̂1n) + op(1).
The last equation comes from β̂20−β20 = β̂2n−β20+A−122A21(β̂1n−β10)+op(1).
Thus Corollary 2.5.7 holds because n1/2(β̂1n − β10) converges in distribution to a
N(0, (A11 −A12A−122A21)−1) distribution under H˜0.
Auxiliary information can be used to not only increase the precision of es-
timated treatment effects, but to also increase power in hypothesis testing. To
evaluate power, we need to derive the asymptotic distribution of the test statis-
tic under the alternative hypothesis. We shall consider the contiguous alternative
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which deviates from the null by the order of O(n−1/2); cf. Hajek, Sidak and Sen













j ), i = 1, 2 and j = 1, 2.
Theorem 2.5.8. Suppose that Conditions C1-C3 are satisfied. Then under the
sequence of contiguous alternatives Ha : β = βa = β0 + h/
√
n, the empirical
likelihood ratio test statistic T1n converges in distribution to a noncentral χ
2 with
degrees of freedom q and noncentrality parameter hTAh.
Proof. Following the same steps as in the proof of Theorem 2.5.3, we can show
that
n1/2A−1/2(β̂n − β0)→ N(A−1/2h, I).
Taking the Taylor series expansion of the empirical likelihood ratio test statistic
at β0, we have
T1n = n
1/2(β̂n − βa + h/
√
n)TA(β0)n
1/2(β̂n − βa + h/
√
n) + op(1),
where the second equality comes from βa = β0 + h/
√
n being a sequence of
contiguous alternatives. Therefore, T1n → χ2q with noncentrality parameter hTAh
as n→∞ under the alternative Ha : β = βa = β0 + h/
√
n.
Similarly, the noncentrality parameter of the limiting χ2 distribution becomes
the projected Fisher information when there are nuisance parameters.
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Corollary 2.5.9. Under the same assumptions as those in Theorem 2.5.8 and
with Ha replaced by H˜a : β1 = β1a = β10 + h1/
√
n, the empirical likelihood ratio
test statistic T2n in (2.55) converges in distribution to a noncentral χ
2 with degrees
of freedom q1 and noncentrality parameter h
T
1 (A11 −A12A−122A21)h1.
Proof. Similarly to the preceding proof, we have under the contiguous alternative
T2n = n
1/2(β10 − β̂1n)T (A11 −A12A−122A21)n1/2(β10 − β̂1n) + op(1).
Similarly to Theorem 2.5.3, we can show that when H˜a : β1 = β1a = β10 +
h1/
√
n is true, (A11 −A12A−122A21)−1/2n1/2(β10 − β̂1n) converges in distribution
to N((A11 −A12A−122A21)−1/2h1, I), which implies Corollary 2.5.9.
It can be seen that the empirical likelihood approach reproduces the standard
asymptotic results in parametric likelihood theory (Cox and Hinkley 1974). Similar
to the estimation problem, adding more constraints will result in more powerful
tests. When the number of constraints goes to infinity, the corresponding tests
become asymptotically most powerful.
2.6 Numerical studies
In this section, we discuss computational issues arising from implementing the
constrained optimization problems and report simulation results associated with
the empirical likelihood based covariate adjustment method.
The primary step in computing the empirical likelihood is to maximize (2.20)
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where λ and γ are the Lagrange multipliers. In practice we use a modified natural
logarithm log? as defined in Owen (2001) instead of log. Thus, we obtain estimators
for p and β by differentiating P? with respect to p, β, λ and γ and setting them
to 0.
Working directly with n+ q+ r+1 free variables involves gradient and Hessian
matrices of daunting dimensions. Alternatively we may use the two-stage New-
ton algorithm as discussed in Section 2.5.1 that can eliminate some parameters.
Nonetheless, unlike the usual testing case where β is fixed at β0, the outer stage in
the two-stage Newton algorithm, i.e. minimization over β while keeping λ fixed,
is difficult in practice because of the possibility of a non-positive definite Hessian
matrix. Zedlewski (2008) points out that “Concentrating out some parameters
leads to a smaller optimization problem, but it can make it more difficult. Thus
the two-stage Newton algorithm is fast but unreliable and can lead to frustrating
convergence problems. In most cases n is much greater than q + r, so the largest
block of the Hessian is an n× n diagonal matrix.”. Further, the largest block is a
negative definite matrix as well. In our implementation, we use a Matlab package
“matElike”, which solves the primal problem by including modern optimization
codes exploiting matrix sparsity. We find the package to be both robust and fast.
The link to the Matlab package and the code to implement our method can be
found at http://www.stat.columbia.edu/~xwu/software.html.
2.6.1 Estimation
The simulation results reported below are all based on 5000 Monte Carlo replica-
tions. The sample size is chosen to be 200 throughout. We consider the case of
two treatment groups with the treatment indicator Z generated with P (Z = 0) =
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P (Z = 1) = 0.5. The response variable Y is binary with logit{E(Y |Z)} = β1+β2Z.
The parameter of interest is either β = (β1, β2)
T or β2.
In the first scenario, the auxiliary covariate X is generated as a one dimensional
Normal random variable with mean 0 and different variances. The magnitude of
the variance correlates with the influence of X on the response. Given Z and X, Y
is then generated as Bernoulli according to logit{P (Y = 1|Z = g,X)} = α0g+αgX,
where α00 = 0.3, α01 = 1, α0 = 1, α1 = 1.5 and g = 0 or 1.
From Table 3.1 we see that when the standard deviation of X is 2, the Monte
Carlo standard errors gradually decrease and approach the optimal ones. From
“marginal” to “5 Fourier”, the standard errors drop significantly. However, ad-
ditional constraints beyond “5 Fourier” do not appear to have much impact on
further variance reduction. Note that a large number of additional constraints re-
quire substantially more computing time. Thus, we will only compare the results
of “marginal” with “5 Fourier” in the other cases. A single (i.e., nonparallel) pro-
cess that calculates the maximum empirical likelihood estimate and the p-value for
testing the null hypothesis of no treatment difference takes, on average, less that 2
seconds to run for a data set of 200 samples using 5 constraints. The computation
time is estimated using a 2.33GHz processor on a server with 8GB RAM.
Table 3.1 also shows that the means of Monte Carlo estimates differ from the
true value of β at the third decimal place and the coverage probabilities are around
0.95. The Monte Carlo standard errors of estimates from five estimating equations
are generally smaller than those from marginal models. The improvement becomes
more pronounced when the variance of X becomes larger. Also, the average length
of 95% Wald confidence intervals are smaller than those of marginal models.
In the second scenario, the link function is quadratic in X, i.e., logit{P (Y =
1|Z = g,X)} = α0g + αgX2, with the same α0g and αg values, g = 0, 1. From
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Table 2.3: Bias and Standard Error Comparisons When Logit is Linear in X.
Method True β MC Bias OptStd MC Std CovProb avlen
X ∼ N(0, 0.52)
marginal 0.2832 0.0033 0.1992 0.2025 0.9520 0.7960
0.6096 0.0063 0.2872 0.3007 0.9486 1.1801
5 Fourier 0.2832 0.0036 0.1992 0.2027 0.9500 0.7870
0.6096 0.0056 0.2872 0.2968 0.9468 1.1536
X ∼ N(0, 12)
marginal 0.2479 0.0010 0.1929 0.2025 0.9520 0.7940
0.4634 0.0063 0.2585 0.2988 0.9472 1.1562
5 Fourier 0.2479 0.0011 0.1929 0.1992 0.9496 0.7718
0.4634 0.0049 0.2585 0.2812 0.9424 1.0785
X ∼ N(0, 22)
marginal 0.1814 0.0040 0.1800 0.1995 0.9526 0.7912
0.2792 0.0003 0.2110 0.2951 0.9452 1.1324
5 Fourier 0.1814 0.0043 0.1800 0.1873 0.9518 0.7337
0.2792 -0.0018 0.2110 0.2439 0.9418 0.9292
7 Fourier 0.1814 0.0030 0.1800 0.1860 0.9494 0.7186
0.2792 0.0008 0.2110 0.2341 0.9442 0.8846
9 Fourier 0.1814 0.0032 0.1800 0.1857 0.9464 0.7101
0.2792 0.0008 0.2110 0.2311 0.9384 0.8631
11 Fourier 0.1814 0.0032 0.1800 0.1852 0.9448 0.7037
0.2792 0.0007 0.2110 0.2293 0.9340 0.8490
NOTE: In all the tables, ‘marginal’ means using empirical likelihood
method with 2 marginal estimating equations Y − φ(β1 + β2Z)
and Z
(
Y − φ(β1 + β2Z)
)
, while “5 Fourier” has three additional
estimating equations 2Z − 1, √2(2Z − 1) sin[2piFn(X)] and√
2(2Z − 1) cos[2piFn(X)], where Fn(X) is the empirical cumulative
distribution function of X. MC Bias is Monte Carlo bias, OptStd
is the asymptotic standard error obtained according to the sandwich
formula, MC Std is the Monte Carlo standard error, CovProb is the
coverage probability of 95% Wald confidence intervals and avlen is
the average length of those confidence intervals.
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Table 2.4: Bias and Standard Error Comparisons When Logit is Quadratic in X.
Method True β MC Bias OptStd MC Std CovProb avlen
X ∼ N(0, 0.52)
marginal 0.5298 0.0057 0.2059 0.2093 0.9516 0.8160
0.7758 0.0094 0.3169 0.3266 0.9536 1.2683
5 Fourier 0.5298 0.0061 0.2059 0.2088 0.9480 0.8090
0.7758 0.0088 0.3169 0.3257 0.9524 1.2523
X ∼ N(0, 12)
marginal 0.9664 0.0106 0.2182 0.2307 0.9476 0.8845
0.8105 0.0182 0.3466 0.3795 0.9494 1.4450
5 Fourier 0.9664 0.0111 0.2182 0.2254 0.9448 0.8604
0.8105 0.0156 0.3466 0.3648 0.9502 1.3800
Table 3.2, we see that the coverage probabilities are satisfactory and close to their
nominal levels as in the first scenario. The biases are slightly larger, however,
they are still small relative to the standard errors. As expected, the Monte Carlo
standard errors and the average lengths of 95% Wald confidence intervals from five
estimating equations are smaller than those from the two marginal ones.
In the third scenario, there are two auxiliary covariates X1 and X2 and the
response Y is generated as logit{P (Y = 1|Z = g,X)} = α0g + α1gX1 + α2gX2,
g=0,1, with α00 = 0.3, α01 = 1, α10 = 1, α11 = 1.5, α20 = 2, α21 = 1.5. The estimat-
ing equations for the marginal method remain the same since there is no covariate
adjustment involved. Let κ(Z) =
√
2(2Z − 1) and Wk = 2piFn(Xk), k = 1, 2. The
empirical likelihood method with constraints, κ(Z), κ(Z) sin(W1), κ(Z) cos(W1),
κ(Z) sin(W2), κ(Z) cos(W2), except the marginal estimating equations is denoted
by “7 Fourier”. From Table 3.3, the performance of the estimates is similar to that
in the previous two scenarios.
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Table 2.5: Bias and Standard Error Comparisons When Logit Contains Two Co-
variates.
Method True β MC Bias OptStd MC Std CovProb avlen
X1 ∼ N(0, 12), X2 ∼ N(0, 22)
marginal 0.1061 -0.0003 0.1649 0.2005 0.9558 0.7883
0.3157 0.0043 0.1828 0.2933 0.9494 1.1282
7 Fourier 0.1061 -0.0009 0.1649 0.1761 0.9526 0.6813
0.3157 0.0051 0.1828 0.2311 0.9438 0.8716
X1 ∼ N2(0, 12), X2 ∼ N(0, 22)
marginal 0.4389 0.0063 0.1688 0.2032 0.9550 0.8069
0.5493 0.0056 0.1985 0.3072 0.9486 1.2023
7 Fourier 0.4389 0.0052 0.1688 0.1825 0.9494 0.7012
0.5493 0.0041 0.1985 0.2490 0.9458 0.9396
X1 ∼ N2(0, 0.52), X2 ∼ N2(0, 12)
marginal 1.4746 0.0149 0.2482 0.2594 0.9562 1.0201
0.5813 0.0233 0.3857 0.4310 0.9498 1.6363
7 Fourier 1.4746 0.0144 0.2482 0.2512 0.9518 0.9771
0.5813 0.0224 0.3857 0.4126 0.9486 1.5485
NOTE: The logit is either quadratic (X ∼ N2(·, ·)) or linear (X ∼
N(·, ·)) in each covariate.
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Table 2.6: Power Comparison When Logit is Linear in X.
marginal 5 Fourier
X β10 β20 CovProb Power CovProb Power
N(0, 0.52) 0.2125 0.8304 0.9498 0.7928 0.9492 0.8216
N(0, 12) 0.1379 0.8207 0.9494 0.7826 0.9458 0.8682
N(0, 22) 0.0386 0.8182 0.9486 0.7938 0.9436 0.9568
Table 2.7: Power Comparison When Logit is Quadratic in X.
marginal 5 Fourier
X β10 β20 CovProb Power CovProb Power
N(0, 0.52) 0.8511 1.0599 0.9442 0.8428 0.9448 0.8498
N(0, 12) 0.9662 0.9359 0.9464 0.7356 0.9482 0.7724
2.6.2 Testing
With the same data generating process as in the preceding subsection, the corre-
sponding hypothesis testing results are presented in Tables 3.4, 2.7 and 2.8. In
each scenario, the profile empirical likelihood ratio test is used to test the null hy-
pothesis H˜0 : β2 = 0. CovProb denotes coverage probabilities for testing β2 = β20.
We have the following observations. First, in all three tables, both coverage prob-
abilities of the profile empirical likelihood ratio tests are close to the nominal 95%
level. Second, the attained power from 5 estimating equations is larger than that
from marginal estimating equations. Third, when X is one dimensional, the gain
in power is more significant as the standard deviation of X increases. Note that
in each scenario, β10 and β20 are the true values. The profile empirical likelihood
ratio test is used to test the null hypothesis H˜0 : β2 = 0. CovProb are the coverage
probabilities of tests β2 = β20.
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Table 2.8: Power Comparison When Logit Contains Two Covariates.
marginal 7 Fourier
X1, X2 β10 β20 CovProb Power CovProb Power
N(0, 12), N(0, 22) 0.0694 0.8461 0.9488 0.8166 0.9430 0.9308
N2(0, 12), N(0, 22) 0.2468 0.7012 0.9418 0.6584 0.9438 0.8636
N2(0, 0.52), N2(0, 12) 1.1701 0.8342 0.9496 0.5873 0.9478 0.6140
2.7 Application
We apply the proposed empirical likelihood based approach to the Global Use of
Strategies to Open Occluded Coronary Arteries (GUSTO)-I trial data, which were
kindly provided to us by Karen Pieper from the Duke Clinical research Institute.
The primary endpoint was 30-day death, which occurred in 6.29% of 10366 patients
randomly assigned to tissue plasminogen activator (TPA) (g=1), 7.32% of 10354
patients randomly assigned to skreptokinase (SK) with IV heparin (g=2), 6.99%
of 10303 patients randomly assigned to a combination of SK and TPA (g=3) and
7.24% of 9773 patients randomly assigned to SK with SQ heparin (g=4). Besides
treatment assignment and outcome, some baseline auxiliary covariates concern-
ing demographics (age, sex, weight, height), risk factors (hypertension, diabetes,
smoking, hypercholesterolemia), other history (family history of MI, previous MI,
previous angina, previous revascularization) and presenting characteristics (blood
pressure, tachycardia, anterior infarct location, killip class, ST elevation on elec-
trocardiography) were recorded on each subject. In Steyerberg et al. (2000),
the relative prognostic strength of 17 baseline covariates was evaluated by their
univariate χ2 model, which was calculated as the difference in -2 log-likelihood
between a univariate logistic regression model with and without the characteristic.
The strongest prognostic factor was age and this was further confirmed by the R2
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measure on the log-likelihood scale, which approximately indicated the percentage
of variance explained (see Figure 2.1). Except calculating correlations, adjustment
for important predictors such as age is always recommended in the case of short-
term death after acute myocardial infarction. Thus, we will compare unadjusted
and age-adjusted results for the four treatment groups.
The marginal model between the 30-day death (Y) and treatment assignment
(Z) is given by logit{E(Y |Z)} = β1+β21(Z=2)+β31(Z=3)+β41(Z=4). For the age(X)
adjustment, we use 9 auxiliary constraints (1(Z=g)−0.25), (1(Z=g)−0.25)Fn(x) and
(1(Z=g) − 0.25)F 2n(x), g = 2, 3, 4, where Fn(x) is the empirical c.d.f. of age.
The unadjusted estimates (β̂1, β̂2, β̂3, β̂4) are (-2.7014, 0.1630, 0.1129, 0.1517)
with standard errors (0.04109, 0.05619, 0.05670, 0.05557). Estimates adjusted for
age are (-2.7014, 0.1628, 0.1126, 0.1521) with standard errors (0.04109, 0.05619,
0.05670, 0.05556). The p-values for the unadjusted and adjusted hypothesis testing
of β2 = β3 = β4 = 0 are 0.0136 and 0.0135, respectively.
The unadjusted test is already significant, so the additional improvement in p-
value after covariate adjustment only reconfirms the scientific conclusion. However,
if the sample size were smaller, the change in p-value might be more consequential.
For illustrative purposes, we randomly draw a subsample of size 20000 from the
complete data and pretend that is what we had in reality. In one of these cases,
the p-values for the unadjusted test of β2 = β3 = β4 = 0 is 0.0391 while it becomes
0.0362 after adjusting for age. In another case, it changes from 0.0508 to 0.0458.































































































Figure 2.1: Relative prognostic strength of 17 baseline covariates.




Testing for differences between two populations is one of the classical problems in
nonparametric inference. For univariate data, there exists an extensive literature
(Ha´jek & S˘ida´k, 1967; Hollander & Wolfe, 1973; Lehmann, 1975). A common
feature in most approaches is that the test statistics are based on the ranks of the
observations, which are invariant under monotone transformations, in the “pooled”
sample that combines the sample data from each of the two populations. As a re-
sult, the test statistics are distribution free under the null hypothesis. An intrinsic
difficulty in extending these tests to the multivariate case is the fact that there is
no natural order on p-dimensional (p ≥ 2) space, and monotone transformation of
each coordinate does not necessarily lead to the uniform distribution on the unit
p-cube. Thus, the resulting test statistics are no longer distribution free under
the null hypothesis in the multivariate case. Since the multivariate case has been
studied far less thoroughly, there has always been interest in finding nonparametric
approaches. As a generalization of the univariate ordering of the pooled sample,
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Friedman & Rafsky (1979) proposed a multivariate run test based on the minimal
spanning tree of the observations. Based on the number of nearest neighbor type
coincidences, Henze (1988) developed a procedure which can be implemented us-
ing an approximate permutation test. Liu & Singh (1993) introduced the concepts
of multivariate median and data depth for nonparametric analysis of multivariate
data.
More recently, by examining the number of points from different groups that
fall into local neighborhoods, Hall & Tajvidi (2002) developed a permutation based
approach to testing for group differences. Rosenbaum (2005), on the other hand,
introduced the concept of optimal non-bipartite matching and proposed what he
called the cross-match test. Both approaches make use of certain inter-point dis-
tances so that the high-dimensional structure is reduced to the univariate situation.
Survival analysis is one of the most active areas where nonparametric tests are
the gold standard, and the properties of these tests are well understood. Most
notably, the log-rank test and its weighted versions are commonly used for testing
for treatment effects when survival time is the outcome variable. We refer to Mantel
& Haenszel (1959), Mantel (1966), Gehan (1965), Peto & Peto (1972) and Prentice
(1978) for some of the initial developments and Gill (1980) for the counting process
and associated martingale representations of the weighted log-rank test statistics.
The nonparametric nature, the flexibility of the weight functions, the well-
understood theoretical properties and the widely available software tools suggest
the utility of using the class of weighted log-rank statistics to connect the problem
of testing for differences in high-dimensional data to survival analysis. To that end,
we propose a survival analysis approach to the multivariate K-sample problem, by
converting multivariate data into survival data. Using this conversion, we are able
to make use of powerful weighted log-rank tests to develop a class of nonparamet-
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ric tests. This approach is simple to implement and to adapt to different space
configurations.
We develop large sample properties for the proposed statistics by studying the
underlying score processes. By centering the scores at their marginal intensities,
we establish their weak convergence to Gaussian random fields under the null and
contiguous alternative hypotheses. For the Kolmogorov-Smirnov-type and Crame´r-
von Mises-type tests, we also establish consistency against any fixed alternative.
As a practical means to obtain approximate cutoff points, we propose a simulation
based resampling method that is easy to implement and has rigorous theoretical
justification.
The rest of the chapter is organized as follows. The proposed tests and their
theoretical properties are given in the Section 3.2. Section 3.3 is devoted to simu-
lation studies. In Section 3.4, the method is applied to two real data sets.
3.2 A class of weighted log-rank based test statis-
tics
3.2.1 Weighted log-rank score process and test statistics
We consider first the case of two populations. Let X1, . . . , Xn1 be a p-dimensional
random sample from a population with distribution function F1 andXn1+1, . . . , Xn1+n2
be a second random sample from distribution F2. Suppose that the null hypothesis
of interest is
H0 : F1 = F2, (3.1)
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and that the alternative hypothesis is its complement. For any fixed point x in
Rp, let Ti(x) = d(Xi, x), where d is a certain distance metric on Rp. Typically d
is taken to be the Euclidean distance, d(Xi, x) = ‖Xi − x‖. Furthermore, define
Ti(x)-induced counting process
Ni(x; t) = I(Ti(x) ≤ t), t ≥ 0, i = 1, . . . , n,
where I(·) denotes the indicator function and n = n1 + n2.
By converting the original observations X1, . . . , Xn into T1(x), . . . , Tn(x), we
may regard Ti as survival times and connect the two sample problem with the
well-studied weighted log-rank tests for survival data. Define the weighted log-
rank score process










j=1 ZjI(Tj(x) ≥ s)∑n
j=1 I(Tj(x) ≥ s)
}
dNi(x; s), (3.2)
where Zi = I(i > n1) and Wx(s) is a weight function. A widely used class of
weight functions in survival analysis corresponds to the G-ρ class (Harrington and
Fleming 1982) of weighted log-rank test statistics, where Wx(t) = w(Fˆ (x; t−)),
w(u) = (1−u)ρ, 1− Fˆ (x; t−) is the Kaplan-Meier estimate of the survival function
from T1(x), . . . , Tn(x) and ρ ≥ 0 is a tuning parameter. Let t˜ be an upper bound
on the distances Ti, i = 1, . . . , n. For a fixed x, Uw(x; t˜) is the usual log-rank test
statistic for ρ = 0 and it becomes the Peto-Prentice extension of the Wilcoxon
statistic when ρ = 1. The choice of ρ depends on the projected alternatives: if
the difference in the two corresponding hazards is more pronounced for smaller
t values, then a larger ρ is preferred. Thus, if the group difference lies in “local
features”, the Peto-Prentice statistic achieves greater efficiency. For any fixed x,
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since (3.1) implies that the Ti have a common distribution, it follows from the usual
counting process-martingale approach to survival analysis (Gill, 1980; Flemming
& Harrington, 2005; Anderson et al., 1993) that Uw(x; t) is a zero-mean martingale
in t for a suitable σ-filtration under H0. Viewed as a two-parameter process (of
x and t), Theorem 3.2.1 below shows that Uw converges weakly to a zero-mean





i I(Ti(x) ≥ t) and Γk(x; t) = lim
n−→∞
Γ̂k(x; t), k = 0, 1 throughout.
Theorem 3.2.1. Under H0 : F1 = F2, the weighted log-rank score process Uw(·; ·)
converges weakly to a zero-mean Gaussian random field G0(·; ·) with covariance





















whereMi(x; t) = Ni(x; t)−
∫ t
0 I(Ti(x) ≥ s)dΛ(x; s) and Λ(x; s) is the common cumulative
hazard function of Ti(x).
Proof. Under H0, for each fixed x, Ti(x), i = 1, . . . , n, are iid random variables.
By the standard counting processes theory, Mi(x; t), i = 1, . . . , n, as processes in
t, are zero-mean martingales. Hence, we can write


























is also a martingale. By the law of large numbers, the predictable variation of (3.3)
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converges to 0. Therefore (3.3) is of order op(1) and consequently,








Zi − Γ1(x; s)
Γ0(x; s)
}
dMi(x; s) + op(1). (3.4)
The first term on the right-hand side of (3.4) is a sum of independent zero-mean
random variables. By the classical multivariate central limit theorem, Uw(·; ·)
converges in finite dimensional distributions to a Gaussian random field, whose
covariance function is given by C(x1, t1;x2, t2) in Theorem 3.2.1.
It remains to prove the “tightness” of Uw(·; ·). This can be done by applying
modern empirical process theory, as given in Pollard (1990) and van der Vaart and
Wellner (2000).
Using (3.2) as the basic vehicle, we can construct a variety of test statistics.
The main idea is to combine the weighted log-rank statistics at different x locations
and to introduce censoring to the observed survival times so that the resulting test
statistic has more robust power. Two common ways to summarize over x cor-
respond to the Kolmogorov-Smirnov (K-S) sup-type and the Crame´r-von Mises
(C-vM) integral-type approaches. To those ends, we propose the following statis-
tics: U1 = sup
x∈D




w(x; t˜)pi(x, t˜)dx, where D is a suitably
chosen subset of Rp and pi(x, t) is a weight function. Here t˜ is typically an upper
bound, which is commonly used in survival analysis to control possible tail insta-
bility. Let T(1)(x), . . . , T(n)(x) denote the order statistics from {T1(x), . . . , Tn(x)}.
We may set t˜ to be the kth order statistic T(k)(x), mimicking the type II censoring
in survival analysis. The use of T(k)(x) localizes the discrepancy between the two
populations. For example, if x is surrounded locally by the first group of X’s,
then, with a small k, Uw(x;T(k)(x)) tends to take a negative value. Taking a small
k is in the spirit of k-nearest neighbor method in nonparametric regression. This
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idea can be generalized to other censoring schemes to accommodate different data
patterns.
The weak convergence of Uw can be used to derive limiting distributions of U1
and U2, which are functionals of Uw. The following corollary can be shown by
applying continuous mapping theorem to Theorem 3.2.1.
Corollary 3.2.2. Let G0 be the Gaussian random field introduced in Theorem 1.





0(x; t˜)pi(x, t˜)dx, respectively.
REMARK. It is intuitive that selection of D should not be beyond the support
of the underlying multivariate distributions. Choosing D to be the support is
asymptotically equivalent to taking D to be the observed sample points, due to
the weak convergence of Uw. The latter enables us to avoid maximizing a statistic
over an unbounded high dimensional space, which could be difficult and time
consuming. This is especially so when the dimension of X is much larger than the
sample size n. Note that the zero-mean property of Uw under the null hypothesis
remains the same, irrespective of the dimension.
Because of their intractable forms, the limiting distributions in Corollary 3.2.2
do not immediately lead to the cutoff points for the corresponding tests. An al-
ternative way is to simulate replicates of processes U∗w, which have asymptotically
the same limiting distribution as that of Uw, thereby constructing respective func-
tionals of U∗w that numerically approximate the distribution of U1 and U2. Such
an approximation is theoretically justified by the following result.










where M̂i(x; t) is the same as Mi(x; t) except with Λ(x; t) being replaced by the
Nelson-Aalen estimator (Anderson et al., 1993) and Vi are independent standard
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normal random variables that are independent of {(Xi, Zi)}ni=1, the observed data.
Then, the conditional distribution of U∗w given data {(Xi, Zi)}ni=1 converges to the
same limiting Gaussian random field G0 as that of Uw.
Proof. Conditioning on the data {(Xi, Zi)}ni=1, {Vi}ni=1 are the only random compo-
nents in U∗w. Since Vi are generated to be iid standard normals and independent of
the data, it follows from the central limit theorem and a straightforward covariance
calculation that U∗w converges in finite dimensional distributions to a zero-mean
Gaussian process with the same covariance function C(x1, t1;x2, t2) defined in The-
orem 3.2.1. Thus, it suffices to prove the tightness of U∗w, which can be done by
making use of the functional central limit theorem (Pollard 1990); see Lin et al.
(2000) for arguments in a more general case.
Note that the conditional distribution of U∗w given {(Xi, Zi)}ni=1 can be sim-
ulated by repeatedly generating random sequences {Vi}ni=1. Therefore, we can
approximate the distribution of any functional of Uw by that of the corresponding
functional of U∗w, which can be obtained via simulations. This random weighting







dM̂i(x; s), i =
1, . . . , n, are fixed at their observed values for each sample of U∗w. We refer to Lin et
al. (2002) for a comprehensive discussion of such an approach and related methods.
Specifically, to obtain the cutoff value for U1 or U2, we can either use a permutation
test by randomly dividing n observations into two groups of sizes n1 and n2 or uti-





x∈D{U∗w(x; t˜)}2pi(x, t˜)dx when the sample size is relatively large.
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3.2.2 Extension to the K-sample case
Suppose for each k, {Xki}nki=1 is a random sample from a population with distri-
bution function Fk on Rp, k = 1, . . . , K. We wish to test the null hypothesis
that F1 = . . . = FK against the complementary alternative. Similarly to the
two-sample case (K = 2), for each fixed point x ∈ Rp, let Tki(x) = d(Xki, x)
and Nki(x; t) = I(Tki(x) ≤ t). In the K-sample case, the weighted log-rank score
process is Uw = (Uw1, . . . , Uw(K−1))T , where




Wx(s){dNk(x; s)− Γk(x; s)
Γ·(x; s)
dN·(x; s)},
where Nk(x; t) =
∑nk
i=1Nki(x; t), N·(x; t) =
∑K
k=1Nk(x; t), Γk(x; t) =
∑nk
i=1 I(Tki(x) ≥
t) and Γ·(x; t) =
∑K
k=1 Γk(x; t). Under some mild regularity conditions, we have
the following result.
Theorem 3.2.4. Under H0 : F1 = F2, the weighted log-rank score process Uw con-
verges weakly to a zero-mean multivariate Gaussian random field with covariance























k=1 nk, δkl = I(k = l),Mki(x; t) = Nki(x; t)−
∫ t
0
I(Tki(x) > s)dΛ(x; s)
and Λ(x; t) is the common cumulative hazard function of Tki(x).
For statistics defined as functionals of Uw, it is again difficult to obtain ana-
lytic forms of their limiting distributions. We therefore propose to use a simulation
based random weighting method to approximate the limiting distributions and to
obtain cutoff points. For theoretical justification, we need the following general-
ization of Theorem 3.2.3.
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where Mˆki(x; t) is the same as Mki(x; t) with Λ(x; t) replaced by the Nelson-Aalen
estimator, Vki are independent standard normals and are independent of the data.
Then, the conditional distribution of U∗w = (U
∗
w1, . . . , U
∗
w(K−1))
T given the data
converges to the same limiting multivariate Gaussian random field as in Theo-
rem 3.2.4.
3.2.3 Asymptotic properties under alternative hypotheses
In this section, we establish asymptotic properties for the proposed test statistics
under alternative hypotheses. We first consider the case of a fixed alternative and
show that the Kolmogorov-Smirnov-type and von Mises-type tests are consistent
against any such alternative.
Theorem 3.2.6. Under any fixed alternative F2 6= F1, for any sequence of random







|Uw(x; t)| > cn
)
= 1








U2w(x; t)pi(x, t)dtdx > cn
)
= 1.
Proof. Based on the fact that there exists a t ∈ [0,∞) making the weighted log-
rank test consistent, it suffices to show that if X and Y differ in distribution, then
there exists an x such that d(X, x) and d(Y, x) follow different distributions. We
prove this by contradiction. Suppose for any x, d(X, x) and d(Y, x) have the same
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distribution, then for any ∆ > 0,
P (d(X, x) ≤ ∆)
∆p
=
P (d(Y, x) ≤ ∆)
∆p
.
Letting ∆ go to zero on both sides, we know that fX(x) = fY (x) at any x, where
fX and fY are respective densities. This contradicts the assumption.
REMARK Because Uw is standardized and converges weakly, the critical val-
ues for these tests, for example those obtained via the random weighting method
discussed in §3.2.1, should converge in probability to constants under the null and
under the alternative. Therefore, the theorem above shows that the two types of
tests are consistent when summarized over all x and t. However, for a single pair
of x and t, it is not hard to see that Uw(x, t) itself may not have any power. For
instance, if the first population follows Np(µ,Σ) and the second follows Np(−µ,Σ)
and x is fixed at the origin, then Uw(x, t) will have no power due to symmetry.
It is customary to study the asymptotic power of test statistics by considering
contiguous alternatives. We next derive the limiting distributions of the proposed
tests under such contiguous alternatives. Following Ha´jek and S˘ida´k (1967), let
Pn be the sequence probability measures representing the null and Qn its contigu-
ous alternatives. Denote by dQn
dPn
the Radon-Nikodym derivative between the two
measures.















under Pn. Then, under Qn,
Uw(x; t) converges weakly to a Gaussian random field GQ(x; t) with mean τ(x; t)
and covariance function C(x; t).
Proof. By Le Cam’s third lemma (Ha´jek and S˘ida´k 1967), Uw(x; t) converges in
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finite dimensional distribution to GQ(x; t) under Qn. Moreover, we can show that(
Uw(x; t), log dQndPn
)
is tight by applying empirical process theory, as given in Pollard
(1990) and van der Vaart and Wellner (2000).
Corollary 3.2.8. Under the assumption in Theorem 3.2.7, we have for any t˜
(i) sup
x∈D












Corollary 3.2.8 can be shown by applying continuous mapping theorem to The-
orem 3.2.7. Comparing the limiting distribution in Theorem 3.2.7 with that in
Theorem 3.2.1, we know that the power of the respective tests is governed by the
mean drift τ(x; t) of the Gaussian random field. To gain some insight into the power
properties, we calibrate τ(x; t) in two concrete examples. Let δi = I(‖Xi − x‖ ≤ t),
pz = P (Z = 1) and let Hx be the distribution function of ‖X − x‖ ∧ t.
Example 1. Consider two populations differing in location:
H1 : X ∼ f(· − n−1/2cZ),
where f is the density function of X under the null and c is a p-vector of constants.
The alternative is clearly contiguous toH0 (Ha´jek and S˘ida´k 1967). It can be shown
that the drift function has expression
τ(x; t) = pz(1− pz)E[{δφ ◦Hx(‖X − x‖) + (1− δ)Φ ◦Hx(t)}cTf ′(X)/f(X)],
where φ(u) = w(u) − ∫ u
0
w(v)/(1 − v)dv and Φ(u) = φ(u) − w(u). In particular,
if f is the density for Np(µ, I), where I is the identity matrix, and t = +∞, then
τ(x; t) = −pz(1 − pz)E{φ ◦ H(‖X − x‖)cT (X − µ)}. When µ = 0 and D = {0},
i.e., if under the null hypothesis, X follows a p-variate normal distribution with
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mean zero and if we construct our test statistics using D = {0}, it is easily seen
that τ(x; t) = 0. Thus, the corresponding tests have no power. This is somewhat
surprising since the two populations do differ by a contiguous location shift. This
phenomenon is also validated by simulation studies in section 3.3.2.
Example 2. We next consider two populations differing in scale:
H2 : X ∼ exp(−n−1/2cT1pZ)f(exp(−n−1/2Zc) ∗ ·),
where 1p is a p-vector consisting of all ones and ~a∗~b = (a1b1, . . . , apbp) for p-vectors
~a = (a1, . . . , ap)
T and ~b = (b1, . . . , bp)
T . We can get
τ(x; t) = 2pz(1−pz)E[{δφ◦Hx(‖X − x‖)+(1− δ)Φ◦Hx(t)}(c∗X)Tf ′(X)/f(X)].
If we let t = +∞, f be the density of Np(0, σ20I) and c = c01p, then it simplifies to
τ(x; t) = −2pz(1− pz)c0σ−20 E{φ ◦Hx(‖X − x‖) ‖X‖2}.
In this case, simulation results in section 3.3.2 show that if we let D contain only
one point x, then x = 0 gives the highest power and the farther x moves away
from 0, the lower the power is. In Figure 3.3(d), we can see that when x = 0,
the proposed tests have approximately the same power as the likelihood ratio test,
which is the asymptotically most powerful one.
3.3 Simulations
We conducted extensive simulations to assess the performance of the proposed
method. The results reported here are based on 1000 Monte Carlo data sets. For
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simplicity, we only consider the case of two groups of data points on R2. Two
approaches, fixed and data dependent, are used for choosing D, defined in the
previous section. For the former, D is set to be {(−1 + 0.4i,−1 + 0.4j), i, j =
1, . . . , 5} (see Figure. 3.1(a)). For the latter, D is data dependent and we use
ten points {mg + (0, jsg2),mg + (isg1, 0), g = 1, 2, i, j = −1, 0, 1}, where mg is the
sample mean of the gth group, sgr is the standard deviation of the gth group in
the rth direction (see Figure. 3.1(b)). The definition of ρ in Tables 1-4 is the
same as that in the G-ρ class of weighted log-rank tests discussed in §3.2.1. In the
simulation study, we explore both small and large sample cases. When the total
sample size is small, we apply permutation tests and when it is large, we use the
random weighting method.




















Figure 3.1: Graphs showing (a) the fixed D, and (b) the data dependent D (•:
group 1; N: group 2).
3.3.1 Permutation-based tests
We simulate 15 samples for each group and use 5000 permutations to obtain the
cutoff value. When k is small, there are many ties among the 5000 test statistics.
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Thus, randomization is applied to deal with ties on the boundary of the rejection
region. For example, suppose C is the cutoff value obtained from 5000 permuta-
tions and there might be many test statistics equal to C. Then we reject the null
hypothesis if the observed test statistic is greater than C and we accept the null if
it is smaller than C. If the observed test statistic is equal to C, then we reject the
null with probability q, where q is calculated as (0.05× 5000− C>)/C=, with C>
being the number of test statistics among the 5000 permutations that are greater
than C and C= being the number equaling to C. The gth group of observations is































Here, H0 is the null hypothesis, H1 and H2 are the alternative hypotheses with
location shift and scale difference, respectively.
From Table 3.1, when D is fixed, the type-I error rate is close to its nominal
level 0.05. For data dependent D, the type-I error is inflated to be around 0.06,
which is understandable because the sample size for each group is not large enough
to secure a stable D for each Monte Carlo data set. Under the alternatives, the
performance of Crame´r-von Mises-type integral tests is generally slightly better
than the K-S-type sup test. For each fixed k, the power of the test increases
with the increase of ρ (see Table 3.2 and 3.3). This is because as ρ increases,
observations close to points in D are given more weight in the test statistics; thus,
the procedure becomes more powerful at detecting the local discrepancy between
the two groups. When ρ is fixed, the relationship between power and the value of k
is not necessarily monotone. Since the determination of k depends on the pattern of
the observations, there is no unique approach for determining the optimal censoring
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time. But in this simulated example k = 10 gives us the best overall performance
among the three. Under H2, the power of our method (see Table 3.3) are generally
higher than those reported in Table 2 (between 0.5 and 0.65) in Hall and Tajvidi
(2002).
3.3.2 Random weighting
To validate the large sample properties of the proposed tests, we generate 100 sam-
ples for each group. For each Monte Carlo data set, the standard normal variables
{Vi, i = 1, . . . , n} are generated 105 times to get the cutoff value. Similarly, we































From Table 3.1, the type-I error rate is around 0.05 for both fixed and data de-
pendent D. When the sample size is relatively large, by virtue of the law of large
numbers, the impact of random D on the test statistics becomes negligible. Here,
although the data dependent D contains less points than the fixed D, which saves
computational time, the power associated with the data dependent D is generally
much higher than that associated with the fixed D (see Table 3.2 and 3.3). The
higher power with the data dependent D is due to its more advantageous and more
efficient position in detecting the location shift or scale difference compared to the
fixed D. For the same k or ρ, the power pattern is similar to that in the small
sample case.
Next, we investigate the power properties of the two examples given at the
end of §3.2.3. To avoid the complexity caused by the varying values of x and t,
we only take one spatial point x and let t be large enough so that no censoring
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Figure 3.2: A scatter plot showing the laterality index for story listening and
sentence repetition for patients(4) and controls(•).
is involved. We simulate 100 bivariate normal samples for each group. Since we
know the truth in simulations, we can construct a likelihood ratio test of a simple
alternative against a simple null, which is the optimal test by Neyman-Pearson
lemma. We compare the power performance of the likelihood ratio test, the log-
rank test (ρ = 0) and the Wilcoxon test (ρ = 1) in all the scenarios. For Example 1,
we first fix x at (0, 0). In Figure 3.3 (a), the first sample is generated from a mean-
zero normal and the mean of the second sample gradually deviates from zero. In
Figure 3.3 (b), the mean of the first population is (0.4, 0.4) while that of the second
also gradually deviates from (0.4, 0.4). Comparing the power curves in these two
figures, we observe that the power of the likelihood ratio test remains the same as
expected since the alternative differs from the null by the same amount in these two
scenarios. However, the power of the log-rank or Wilcoxon tests are significantly
higher in Figure 3.3 (b) then in Figure 3.3 (a). This matches the calibration in
§3.2.3 that when the mean and x are both zero, the rank based tests have no power.
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If we let the respective mean of the first and the second population be (0, 0) and
−(0.4, 0.4) while moving x along (0.2i, 0.2i), i = 0, 1, . . . , 5, then Figure 3.3 (c)
shows that the power of the proposed tests increases with i. Likewise, if we let the
variance of the bivariate normal be I and 2I for the first and second population,
respectively and set x to be (0, i), i = 0, 1, . . . , 5, then Figure 3.3(d) shows that the
power of the proposed tests decreases with i . These two examples show that the
choice of x will have impact on the power of the proposed tests.
3.4 Applications
3.4.1 Application to functional magnetic resonance imag-
ing of brain activity data
The functional magnetic resonance imaging (fMRI) of brain activity data set, previ-
ously analysed by Rosenbaum (2005) using a minimum distance pairing approach,
consists of two measurements on each of the 18 subjects. All eighteen subjects
are right handed. Half of them have arteriovenous malformations in the left hemi-
sphere and the other half are normal controls. The two measurements are laterality
indices calculated for listening to a story and repeating a sentence mentally after
listening to it, respectively. When the subject is listening to a story or repeating
a sentence while undergoing fMRI, the number of activated pixels in both the left
and the right hemisphere’s temporal lobe, L and R, are recorded. For each task,
the laterality index is calculated as (L − R)/(L + R); see Lehe´ricy et al. (2002)
for details. The laterality index is a continuous variable measuring the relative
activation of the left and the right hemispheres during the language tasks. In some
extreme cases, the laterality index is 1 if all the increased activation is on the left,
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Figure 3.3: Graphs showing power curves for (a) bivariate normal with location
shift and the mean under the null is (0, 0), (b) bivariate normal with location shift
and the mean under the null is (0.4, 0.4) (c) bivariate normal with mean (0, 0)
against (−0.4,−0.4) while x deviates from the origin and (d) bivariate normal
with variance I against 2I while x deviates from the origin (4: likelihood ratio
test, ◦: log-rank test, +:Wilcoxon test).
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Table 3.4: p-values for FMRI data
Integral Sup
ρ = 0 ρ = 1 ρ = 2 ρ = 0 ρ = 1 ρ = 2
k = 9 0.0196 0.0230 0.0258 0.0292 0.0292 0.0384
k = 18 0.0164 0.0172 0.0204 0.0050 0.0102 0.0266
−1 if all is on the right and 0 if the activation on both sides is the same.
Figure. 3.2 is a scatter plot of the laterality index for sentence repetition against
the laterality index for story listening, with patients indicated by a triangle and
controls indicated by a bullet. The primary goal of the study is to examine whether
the impaired left hemisphere affects the performance of language tasks. To this end,
we implement the weighted log-rank approach to compare two groups in the two-
dimensional space. Due to the small sample size, we use the fixed D constructed
as in the previous section and 5000 permutations to obtain the cutoff value.
Table 3.4 displays the p-values corresponding to the weighted log-rank approach
with variable combinations of the censoring time k and weight ρ. All p-values are
less than 0.05, so the null hypothesis that the distributions of the laterality indices
for two groups are the same, is implausible. This conclusion agrees with that in
Rosenbaum (2005), where the significance level is 0.0259.
3.4.2 Application to prostate cancer DNA microarray data
Worldwide, prostate cancer is the third most common cancer and the cause of
6% of cancer deaths in men (Parkin et al. 2001). In the United States, it is
the most frequently diagnosed and the second leading cause of cancer death in
men (Jemal 2003). The first step to better understanding prostate cancer is
to test whether genes are expressed differentially in tumor compared to nontu-
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mor samples. To explore potential molecular variation, DNA microarray pro-
filing studies are conducted. As a new multiplex technology, DNA microarray
can contain tens of thousands of probes, leading to a high dimensional prob-
lem. To illustrate the proposed method, we study a case-control prostate can-
cer DNA microarray data set (LaPointe 2004). The data set can be downloaded
at http://microarray-pubs-stanford.edu/prostateCA/. The prostate cancer
data set consists of 62 primary prostate tumors (61 adenocarcinomas and one ade-
noid cystic tumor) and 41 matched normal prostate tissues (from the noncancerous
region of the prostate). For each tissue, the expressions of 5153 genes were mea-
sured. So we have 62 + 41 = 103 samples in a 5153-dimensional space. The upper
part of Figure. 3.4 displays the grayscale maps of mean expression value of each
gene for tumor and nontumor groups, respectively. We realign the 5153 genes in
a 72 × 72 matrix by row according to the percentage of missing data, from low
to high, i.e., each row from left to right, the percentage of missing data is non-
decreasing. The last 31 elements in the last row of the matrix are set to zero
just to make up a square matrix. Throughout the following analysis, we use the
permutation tests to obtain the cutoff values.
First we take out the 450 genes without any missing data and apply the
weighted log-rank approach in a 450-dimensional space with D composed of two
450-vectors, each being the mean expression values within the respective group.
The null hypothesis of no difference in distribution is rejected at levels well below
10−3 for all reasonable combinations of ρ and k. Then we narrow down the at-
tention to shorter segments of genes. Specifically, we reshape the 450 genes into a
45×10 matrix (see the bottom part of Figure 3.4) and each time we test for group
difference for one row, i.e., in a 10-dimensional space. Among the 45 rows, there
are 29 rows with extremely small p-values and thus in Figure. 3.5, we only display
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Figure 3.4: Graphs showing grayscale maps of mean gene expressions for (a) 5153
genes in cancer population, (b) 5153 genes in control population, (c) 450 genes in
cancer population, (d) 450 genes in control population.
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the p-value for the rest 16 rows (1, 2, 4, 5, 7, 15, 17, 18, 22, 24, 29, 32, 33, 34, 35, 37).
Note that the patterns of the four graphs are quite similar, which shows the
consistency of the procedure. For some rows, the p-value can drop tremendously
with more samples. For row 29, censoring at the 20th observation from the mean
expression value can not reject the null hypothesis at 5% level while including 50
or 103 samples can detect the difference. This might suggest the distributions for
those rows are quite similar around the mean expression values but differ from
each other over the places far away from the means in a 10-dimensional Euclidean
space. For some other rows, e.g., row 4, censoring at the 20th observation may give
the smallest p-value, which might suggest a discrepancy in a local neighborhood
of the mean expression values. In contrast, the three k values give similar p-values
for some rows, for instance, row 37. This may imply a more uniform distribution
over the 10-dimensional space.
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Figure 3.5: Graphs showing p-values for (a) the integral test when ρ = 0, (b) the
sup test when ρ = 0, (c) the integral test when ρ = 1 and (d) the sup test when
ρ = 1 (◦ : k = 20, N : k = 50, + : k = 103). The p-values are plotted after a log10
transformation.
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Chapter 4
Discussion
Nonparametric covariate adjustment is of importance in analysis of randomized
clinical trial data. When properly done, it can result in efficiency improvement
while maintaining the nonparametric nature of the usual tests. Empirical likelihood
approach is nonparametric, constraint based and efficient in extracting information
from data.
For randomized clinical trials, covariate information with no model assump-
tion can be extracted from certain type of constraints or estimating equations. In
this dissertation, we propose an empirical likelihood based approach for covari-
ate adjustment. The resulting likelihood ratio test is shown to have the usual
Wilks type χ2 approximation, with increased power as the number of constraints
increases. The corresponding maximum empirical likelihood estimate also enjoys
similar asymptotic properties. We demonstrate that the χ2 and normal approxi-
mations continue to hold as the number of constraints grows with sample size. We
further show that in doing so the semiparametric efficiency can be achieved.
One of the practical issues is how to select basis functions in the constraints.
From our experiences with simulations and real data analysis, it appears that
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there is no universal way to deal with this issue. A related issue is how many
basis functions should be used. One ad hoc way to do that is to consider variance
reduction when additional constraints are added. We believe that if initial basis
functions are properly chosen, then only a very small number of constraints will
be needed.
It will be of interest to extend this empirical likelihood based nonparamet-
ric covariate adjustment to other situations, including observational studies. Of
particular importance are survival and longitudinal studies where the response
variables may be dependent or causal. For survival data, Lu and Tsiatis (2008)
have introduced a general model framework for covariate adjustment and derived
a semiparametric efficient score. We believe a similar approach, which makes use
of suitable covariate based constraints and achieves the asymptotic efficiency, can
be developed.
The second part of the thesis utilizes the powerful class of nonparametric
weighted log-rank tests to test the difference between multivariate distributions.
This is done by converting the original observations, possibly in a high dimensional
space, into “survival times”. Such an approach reduces greatly the complexity of
the original problem. It also allows the application of available tools, including
software packages for implementation and large sample properties for theoretical
justification. Because the choice of the weight function is intuitive and well un-
derstood in survival analysis, it may be possible to use the intuition from survival
analysis to gain insights into which weight function or functions should be used in
the original multivariate data.
As a simple example, we take type-II censoring to illustrate the flexibility of
the proposed method. This type of censoring may be viewed as a special kind of
weight functions. By varying the number of failure times to be included, this type of
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censoring magnifies “local” group differences as opposed to more global differences.
In this connection, general weight functions provide even greater flexibility.
The usual asymptotic properties are established for the proposed tests. In
particular, we establish the weak convergence of the basic processes under the
null and contiguous alternative hypotheses. The weak convergence is then used
to derive limiting distributions for the test statistics which are functionals of the
basic processes. The limiting distributions under contiguous alternatives may shed
some light on the asymptotic efficiency of the proposed tests in some simple cases.
Converting spatial points to distances is a crucial component of the proposed
method. Instead of Euclidean space, one may consider a general metric space.
In particular, the method is readily applicable to functional data when a suitable
metric can be introduced on the corresponding function space. Modern empirical
process theory is also applicable to deriving asymptotic properties.
The use of the proposed approach for high dimensional problems is of particular
importance. We believe that asymptotic properties can be extended to very high
dimensional problems, including those with p being larger than n. We further note
that the approach may also be extended to other kinds of high dimensional learning
problems. Investigating the use of the survival analysis approach in classification
problems in high dimensional spaces is worth future effort.
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